書籍詳細

1. 体液生理のあゆみ

P.5 掲載の参考文献

• 1) Cannon, W. B. (1929) Organization for physiological homeostasis. Physiol. Rev., 9, 399.

• 2) Crandall, L. A. and M. X. Anderson (1934), Estimation of the state of hydration of the body by the amount of water available for solution of sodium thiocyanate. Am. Digest. Dis. & Nutr., 1, 126.

• 3) Deane, N., G. E. Schreiner and J. S. Robertson (1951) The velocity of distribution of sucrose between plasma and interstitial fluid with reference to the use of sucrose for the measurement of extracellularfluid in man. J. Clin. Jnvest., 30, 1463.

• 4) Epstein, F. H. (1956) Renal excretion of sodium and concept of a volume receptor. Yale J. Biol. Med., 29, 282.
  pubmed

• 5) Fisher, C., W. R. Ingram and S. W. Ranson (1935) Relation of hypothalamico-hypophyseal system to diabetes insipidus. Arch. Neurol. Psychiat., 34, 124.

• 6) Gamble, J. L. (1947) Chemical Anatomy, Physiology and Pathology of Extracellular Fluid. A lecture syllabus. Harvard University Press, Cambridge.

• 7) Gilman, A. and L. Goodman (1937) Pituitrin anemia. Am. J. Physiology., 118, 241.

• 8) Guadino, M. and M. F. Levitt (1949) Inulin space as a measure of extracellular fluid. Am. J. Physiol., 157, 387.

• 9) Guyton, A. C., A. E. Taylor and H. J. Granger (1975) Circulatory Physiology.II. Dynamics and Control of Body Fluids. Saunders, Philadelphia.

• 10) Hargitay, B. and W. Kuhn (1951) Das Multiplikations-prinzip als Grundlage der Harnkonzentration in der Niere. Z. Electrochem., 55, 539.

• 11) Harris, J. E. (1941) The influence of the metabolism of human erythrocytes on their potassium content. J. Biol. Chem., 141, 579.

• 12) Hevesy, G. and E. Hofer (1934) Estimation of water from the human body. Nature, 134. 879.

• 13) Hirokawa, W, (1908) Uber den osmotischen Druck des Nierenparenchyms. Beitr. Chem. Physiol. Pathol., 11, 458.

• 14) Hoffman, J. F. (1962) The active transport of sodium by ghosts of human red blood cells. J. Gen. Physiol., 45. 837.
  pubmed

• 15) Kokko, J. P. and F. C. Rector (1972) Countercurrent multiplication system without active transport in inner medulla. Kidney int., 2, 214.

• 16) Krough, A. (1946) Croonian Lecture:The active passive exchanges of inorganic ions through the surfaces of living cells and through living membranes generally. Proc. Roy. Soc. B. 133, 140.

• 17) Kuhn, W. and A. Ramel (1959) Aktiver Salztransport als moglicher Einzeleffekt bei der Harnkonzentration in der Niere. Helv. Chim. Acta, 42, 628.

• 18) Landis, E. M. (1926) The capillary pressure in frog mesentery as determined by microinjection. Am. J. Physiol., 75, 548.

• 19) Levitts, P. H., J. Bourdillon, and K. A. Klinghoffer (1935) The volume of the extracellular fluids of the body. J. Clin. Invest., 14, 251.

• 20) MacCallum, A. B. (1903) The inorganic composition of the medusae, aurelia flavidula and cyanea artica. J. Physiol., 29, 213.

• 21) O'Shaughnessy, W. B. (1831) Chemical pathology of malignant Cholera. Lancet, 2, 370.

• 22) Painter, E. E. (1940) Total body water in the dog. Am. J. Physiol., 129, 744.

• 23) Peters, J. P. and D. D. Van Slyke (1931) Quantitative Clinical Chemistry. Vol. 1, Interpretation. Williams & Wilkins, Baltimore. (Vol. 2. Methods, 1932)

• 24) Post, R. L., C. R. Merritt. C. R. Kinsolving and C. D. Albright (1960) Membrane adenosine triphosphatase as a participant in the active transport of sodium and potassium in the human erythrocyte. J. Biol. Chem., 235, 1796.

• 25) Salkowski, E. (1871) Untersuchungen uber die Ausscheidung der Alkalisalze. Arch. path. Anat. Physiol., 53, 209.

• 26) Schmidt, C. (1850) Charakteristik der epidemischen Cholera gegenuber verwandten Transsudations-anomalien. Eine physiologisch. Chemische Untersuchung. Leipzig, Mitau.

• 27) Skou, J. Ch. (1957) The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim. Biophys. Acta, 23, 394.

• 28) Smith, H. W. (1951) The Kidney, Structure and Function in Health and Disease. Oxford Univ. Press, New York.

• 29) Smith, H. W. (1957) Salt and water volume receptors. Am. J. Physiol., 23, 623.

• 30) Soberman, R., B. B. Brodie, B. B. Levy, J. Axelrod, V. Hollander and J. M. Steele (1949) The use of antipyrine in the measurement of total body water in man. J. Biol. Chem., 179, 31.

• 31) Starling, E. H. (1896) On the absorption of fluids from connective tissue spaces. J. Physiol., 19, 312.

• 32) Ussing, H. (1949) Transport of ions across cellular membranes. Physiol. Rev., 29, 127.
  pubmed

• 33) Van Slyke, D. D., H. Wu and F. C. McLean (1923) Studies of gas electrolyte equilibrium in the blood. V. Factors controlling the electrolyte and water distribution in the blood. J. Biol. Chem., 56, 765.

• 34) Verney. E. B. (1947) Antidiuretic hormone and the factors which determine its release. Proc. Roy. Soc, Lond. B., 135, 25.

• 35) Wallace, G, B. and B. B. Brodie (1939) The distribution of administered bromide in comparison with chloride and its relation to body fluid. J. Pharmacol. Exp. Therap., 65, 214

• 36) Wirz, H., B. Hargitay and W. Kuhn (1951) Localization des Konzentrierungs Prozesses in der Niere durch direkte Kryoskopie. Helv. Physiol. Pharmacol. Acta, 9, 196.

2. 体液分布とその組成

P.16 掲載の参考文献

• 1) PITTS, R. F.:"Physiology of the kidney and body fluids" 1967, Year Book Med. Publ. Inc., Chicago.

• 2) KATZ, M. A.:New Engl. J. Med., 289;843, 1973.
  pubmed

• 3) WEISBERG, H. F.:"Water, electrolyte and acid-base balance" 2nd ed., 1962, Williams and Wilkins Co., Baltimore.

3. 体液調節機構

P.25 掲載の参考文献

• 1) Panet, R. & Atlan, H.:J. Membrane Biol. 52 p. 273-280, 1980.

• 2) Skou, J. C.:Biochim. Biophys. Acta 23 p. 394-401, 1957.

• 3) Goldin, S. M.:J. Biol. Chem. 252 p. 5630-5642. 1977.

• 4) Yamaguchi, M. & Tonomura, Y.:J. Biochem. 88 p. 1365-1397, 1980.

• 5) Post, R. L., Hegyvary, C. & Kume, S.:J. Biol. Chem. 274 p. 6530-6540, 1972.

• 6) Fahn, S., Koval, G. J. & Albers, W.:J. Biol. Chem. 241 p. 1882-1888, 1966.

• 7) Skou, J. C.:Quarterly Rev. Biophys. 7 p. 401-434, 1975.

• 8) Tashima, Y.:Hasegawa, M.:Lane, L. K. & Schwartz, A.:J. Biochem. 89p. 249-255, 1981.

• 9) Beeuwkes, R. & Rosen, S. Current Topics in Membrane and Transport. 13p. 343-354, 1980.

• 10) Beauge, L.:Vanadate-potassium interaction in the inhibition of Na, K-ATPase. ed. by Skou, J. C. and Norby, J. G. Academic Press, London p. 373-388, 1979.

• 11) 田島陽太郎, 日本医師会雑誌 84, p.395-401, 1980.

• 12) Proverio, F., Condrescu. Guidi, M. & Whittembury, G.:Biochim. Biophys. Acta, 394 p. 281-292, 1975.

• 13) Jorgensen, P. L.:Biochim. Biophys. Acta, 192 p. 326-334, 1969.

• 14) Edelman, I. S. & Fimognari, G. M. Recent progress in Hormone Research, 24 p. 1-44, 1967.

• 15) Nagel, W. & Crabbe, J.:Pflugers Arch. 385 p. 181-187, 1980.

• 16) Horwitz, B. A.:Federation Proceedings 38 p. 2170-2176, 1979.

P.38 掲載の参考文献

• 1) Green, R., Windhager, E. E. and Giebish, G.:On protein oncotic pressure effects on proximal tubular movement in the rat, Am. J. Physiol., 226, 265, 1974

• 2) Brenner, B. M., Falchuk, K. H., Keimowitz, R. I. and Berliner, R. W.:The relation between peritubular capillary protein concentration and fluid reabsorption by the renal proximal tubule, J. Clin. Invest, 48 1519 1969.

• 3) Thurau, K.:Renal hemodynamics, Am. J. Med., 36, 698, 1964.
  pubmed

• 4) Guyton, A. C., Langston, J. B., Navar, G.:Theory for renal autoregulation by feedback of the juxtaglomerular apparatus, Circ. Res., 15, 187, 1964.

• 5) Thurau, K. u. Schllermann, J.:Die Natriumkonzentration an den Macula densa-Zellen als regulierender Faktor fur das Glomerulum-filtrat (Mikropunktionsversuche), Klin. Wschr., 43, 410, 1965.

• 6) Schnermann, J., Ploth, D. W. and Hermle, M. W.:Activation of tubulo-glomerular feedback by chloride transport, Pflugers Arch., 362, 229, 1976.

• 7) Blantz, R. C., Konnen, K. S. and Tucker, B. J.:Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat, J. Clin. Invest., 57, 419, 1976.

• 8) Imai, M., Seldin, D. W., and Kokko, J. P.:Effect of perfusion rate on the fluxes of water, sodium, chloride, and urea across the proximal convoluted tubule, Kidney Int., 11, 18, 1977
  pubmed

• 9) Haberle, D. A. and Shiigai, T.:Flow-dependent volume reabsorption in the proximal convolution of the rat kidney-The role of glomerular-born tubular fluid for the maintenace of glomerulotubular balance, in New Aspects of Renal Function, Vogel, H. G. and Ullrick, K. J. ed. Exerpta Medica,Amsterdam-Oxford,198, 1978.

• 10) Taylor, A. and Windhager, E. E.:Possible role of cytosolic calcium and Na-Ca exchange in regulation of transepithelial sodium transport, Am. J. Physiol., 236, F505, 1979.
  pubmed

• 11) Ussing, H. H., Erlij, D. and Lassen, U.:Transport pathways in biological membranes, Ann. Rev. Physiol., 36, 17, 1974.

• 12) Rocha, A. S. and Kokko, J. P.:Sodium chloride and water transport in the medullary thick ascending limb of Henle, evidence for active chloride transport, J. Clin. Invest., 52, 612, 1973.
  pubmed

• 13) Sasaki, S. and Imai, M.:Effects of vasopressin on water and NaCl transport across the in vitro perfused medullary thick ascending limb of Henle's loop of mouse, rat and rabbit kidneys, Pflugers Arch., 383, 215, 1980.
  pubmed

• 14) Giebisch, G.:Newer aspects of renal tubular potassium transport, contr. Nephrol, 21, 106, 1980.

• 15) Imai. M.:Calcium transport across the rabbit thick ascending limb of Henle's loop perfused in vitro, Pflugers Arch., 374, 255, 1978
  pubmed

• 16) Sutton, R. A. L, Wong, N. L. M., and Dirks, J. H.:Effects of parathyroid hormone on sodium and calcium transport in the dog nephron, Clin. Sci. Mol. Med., 51, 345, 1976.

• 17) Agus, Z. S., Chiu, P. J. D. and Goldberg, M.:Regulation of urinary calcium excretion in the rat, Am. J. Physiol., 232, F545, 1977.

• 18) Parfitt, A. M. and Kleerekoper, M.:The divalent ion homeostatic system-physiology and metabolism of calcium, phosphorus, magnesium, and bone, in Clinical Disorders of Fluid and Electrolyte Metabolism, 3rd ed. Maxwell, M. H. and Kleeman, C. R. ed., McGraw-Hill Book Co., New York, 269, 1980.

• 19) Schneider, E. G., Goldsmith, P. S., Arnaud, C. D. and Knox, F. G.:Role of parathyroid hormone in the phosphaturia of extracellular fluid volume expansion, Kidney Int. 7, 317, 1975.

• 20) Brautbar, N., Walling, M. W. and Coburn, J. W.:Interactions between vitamin D deficiency and phosphorus depletion in the rat, J. Clin. Invest. 63, 335, 1979.

• 21) Shareghi G. R. and Agus, Z. S.:Magnesium transport in the rabbit cortical thick ascending limb, Clin. Res. 27, 430A, 1979.

• 22) Quamme, G. A. and Dirks, J. H.:Effect of intraluminal and contraluminal magnesium on magnesium and calcium transfer in the rat nephron. Am. J. Physiol., 238, F187, 1980.
  pubmed

• 23) Quamme, G. A. and Dirks, J. H.:Magnesium transport in the nephron, Am. J. Physiol., 239, F393, 1980.
  pubmed

• 24) 藤本守, 小寺邦彦, 松村裕, 佐竹典子, 本田稔, 梶野興三, 内藤和世, 窪田隆裕:Naを伴う共軛輸送系-HCO3-とH+の輸送, 日本臨牀, 37, 261, 1979.

• 25) Hulter, H. N., Sebastian, A., Sigala, J. F., Licht, J. H., Glynn, R. D., Schambelan, M. and Biglieri, E. G.:Pathogenesis of renal hyperchloremic acidosis resulting from dietary potassium restriction in the dog:role of aldosterone, Am. J. Physiol., 238,F79,1980.
  pubmed

• 26) 丸茂文昭, 鈴木潤:酸, 塩基平衡, 図説内科講座, 「腎臓A」, メジカルビュー社 28, 1980.

P.48 掲載の参考文献

• 1) Laragh, J. H., Angers, M., Kelly, W. G., and Lieberman, S.:The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man. J. Am. Med. Assoc, 174:234 1960.

• 2) Kaplan, N. M., and Bartter, F. C.:The effect of ACTH, renin, angiotensinl II, and various precursors on biosynthesis of aldosterone by adrenal slices. J. Clin. Invest. 41:715, 1962.

• 3) Blair-West, J. R., Coghlan, J. P., Denton, D. A., Scoggins, B. A., Wintour, E. M., and Wright, R. D.:The onset of effect of ACTH, angiotensin II and raised plasma potassium concentration on the adrenal cortex. Steroids 15:433, 1970.
  pubmed

• 4) Muller, J.:Regulation of aldosterone biosynthesis. Monographs on Endocrinology. Springer-Verlag, New York 5:103, 1971.

• 5) Saruta. T., Cook, R. and Kaplan, N. M.:Adrenocortical steroidogenesis:Studies on the mechanism of action of angiotensin and electrolytes. J. Clin. Invest. 51:2239, 1972.
  pubmed

• 6) Coghlan, J. P., Blair-West, J. R., Denton, D. A., Fei, D. T., Fernley, R. T., Hardy, K. J., McDougall, J. G., Puy, R., Robinson, P. M., Scoggins, B. A. and Wright, R. D.:Control of aldosterone secretion. J. Endocr. 81:55p, 1979.

• 7) Noth, R. T., McCallum, R. W., Contino, C. and Havelick, J.:Tonic doperminergic suppression of plasma aldosterone. J. Clin. Endocrinol. Metab. 51:64, 1980.

• 8) Carey, R. M,, Thorner, M. O. and Ortt, E. M.:Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. J. Clin. Invest. 66:10, 1980.

• 9) 猿田享男, 近藤和興, 斎藤郁夫, 三角二郎, 中村隆一, 城所澄江, 松木駿:減塩立位, Angiotensin II, ACTH, およびK負荷に伴う血漿 Renin, Aldosterone並びにCortisolの変化, 日内分泌会誌 51:740, 1975.

• 10) Williams, G. H. and Dluhy. R. G.:Fluid electrolyte and acid-base abnormalities in hypertensive disease, in Clinical Disorders of Fluid and Electrolyte Metabolism, edited by Maxwell, M, H, and Kleeman. C. R., McGraw-Hill Book Company, New York, p 703,

• 11) Bayard, F., Cooke, C. R., Tiller, D. J., Beitins, I. Z., Kowarski, A., Walker, W. G. and Migeon C. J.:The regulation of aldosterone secretion in anephric man. J. Clin. Invest. 50:1585, 197I.

• 12) Tucci, J. R., Espiner, E. A., Tagger, P. I., Pauk, G. L. and Lauler, D. P.:ACTH stimulation of aldosterone secretion in normal subjects and in patients with chronic adrenocortical insufficiency. J. Clin. Endocrinol. Metab. 27:568, 1967.

• 13) Saruta, T. and Kaplan, N. M.:Adrenocortical steroidogenesis:the effects of prostaglandins. J. Clin. Invest. 51:2246, 1972.
  pubmed

• 14) Edwards C. R. W., Boscaro M, Miall, P. A., Delitala, G. and Al-dujaili, E. A. S.:Inhibition of aldosterone secretion by histamin-H2 receptor antagonists. Abstracts of VI International Congress of Endocrinology. at Melbourne, 1980, p 505.

• 15) Matsuoka, H., Mulrow, P. J. and Li, C. H.:β-lipotropin:A new aldosterone stimulating factor. Science 209:307, 1980.

• 16) Edelman, D, Funder, J. W. and Edelman, I. S.:Subcellular mechanism in the action of adrenal steroids. Am. J. Med. 53:545, 1972.

• 17) Edelman, I. S.:Mechanism of action of aldosterone:energetic and permeability factors. J. Endocr. 81:p 49, 1979.

• 18) Epstein, M. and Saruta, T.:Effect of water immersion on reninaldosterone and renal sodium handling in normal man. J. Appl. Phsiol. 31:368, 1971.

• 19) Epstein, M.:Renal sodium handling in cirrhosis, in The Kidney in Liver Disease, edited by Epstein, M., ELSEVIER, New York, p 35, 1977.

• 20) Laragh, J. H.:Vasoconstriction-volume analysis for understanding and treating hypertension, in Hypertension Manual, edited by Laragh, J. H., Yorke Medical Books, New York, p 823, 1973.

P.60 掲載の参考文献

• 1) Verney, E. B.:The antidiuretic hormone and the factors which determine its release. Proc. Roy. Soc. Lond. 135:25, 1947.

• 2) Shimizu, K and Hoshino, M.:Application of vasopressin radioimmunoassay to clinical study:Role of vasopressin in hypo-and hypernatremia and some other disorders of water metabolism. Contr. Nephrol. 9:42, 1978.

• 3) Robertson, G. L., Mahr, A., Ather, S. and Sinha, T.:Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J. Clin. Invest. 52:2340, 1973.

• 4) Sladek, C. D. and Knigge, K. M.:Osmotic control of vasopressin release by rat hypothalamo-neurohypophyseal explants in organ culture. Endocrinology, 101:1834, 1977.
  pubmed

• 5) Moses, A. M. and Streeten. D. H. P.:Differentiation of polyuric states by measurement of responses to changes in plasma osmolality induced by hypertonic saline infusions. Am. J. Med. 42:368, 1967.

• 6) Robertson, G. L., Shelton, R. L. and Athar, S.:The osmoregulation of vasopressin. Kidney Int. 10:25, 1976.
  pubmed

• 7) Vincent, J. D. and Hayward, J. N.:Activity of single cells in the osmoreceptor-supraoptic nuclear complex in the hypothalamus of the waking rhesus monkey. Brain Res. 23:105, 1970.
  pubmed

• 8) Anderson, B.:Thirst and brain control of water balance. Am. Scientist. 59:408, 197I.

• 9) 清水倉一:Receptor disease:視束上核下垂体性尿崩症. 日本臨牀 33:10, 1975.

• 10) Share, L. and Claybough, J. R.:Regulation of body fluid. Ann. Rev. Physiol. 34:235, 1972

• 11) Johnson, J. A., Moore, W. W. and Segar, W. E.:Small change in left atrial pressure and plasma antidiuretic hormone titers in dogs. Am. J. Physiol. 217:210, 1969.
  pubmed

• 12) Dunn, F. L., Brennan, T. J., Nelson, A. E. and Robertson, G. L.:The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J. Clin. Invest. 52:3212. 1973.

• 13) Robertson, G. L. and Athar, S.:The interaction of blood osmolality and volume in regulating plasma vasopressin in man. J. Clin. Endocr. Metab. 42:613, 1976.

• 14) 清水倉一, 加藤達雄, 本田勝紀, 岡 博, 織田敏次:原発性副腎機能低下症の1例における低ナトリウム血症とADH分泌異常の病態. 日内会誌 70:82, 1981.

• 15) Mandell, I. N., De Fronzo, R. A. . Robertson, G. L. and Forrest, Jr. J. N.:Role of plasma arginine vasopressin in the impared water diuresis of isolated glucocorticoid deficiency in the rat. Kidney Int. 17:186, 1980.

• 16) Skowsky, W. R. and Kikuchi, T. A.:The role of vasopressin in the impaired water excretion of myxedema. Am. J. Med. 64:613, 1978.
  pubmed

• 17) 清水倉一:Inappropriate secretion of ADH (SIADH), 日本臨床, 38, 2977, 1980.
  Medical*Online

• 18) 清水倉一:アンギオテンシンの中枢作用と体液調節. 医学のあゆみ 81:81, 1974.

• 19) Shimizu, K, Share, L, and Claybaugh, J. R.:Potentiation by angiotensin II of the vasopressin response to an increasing Plasma osmolality. Endocrinology:93, 42, 1973,

• 20) Share, L., Claybaugh, J. R., Shimizu, K., Yamamoto, M. and Shade. R. E.:Role of the renin-angiotensin system and the prostaglandins in the control of vasopressin release. In "Osmotic and Volume Regulation." Ed. Jφrgensen, C. B. et al. Munksgaard, 197

• 21) 清水倉一:プロスタグランディンと腎. 代謝 12:1611, 1975.

• 22) 清水倉一:滲透圧調節系に関する研究-臨床的ならびにsimulationによる実験的考察-. 日本腎臓学会誌 9:251, 1967.

P.70 掲載の参考文献

• 1) Hagitay, B. & Kuhn, W.:Das Multiplikationsprinzip als Grundlage der Harn Konzentrierung in der Niere. Z. Electrochem. 55:539, 1951.

• 2) Kuhn, W. & Ramel. L.:Aktiver Salztransport als moklicher (und warscheinlicher) Einzeleffekt bei der Harnkonzentrierung in der Niere. Helv. Chim. Acta 42:628, 1959.

• 3) Kuhn, W. & Ryffel, k.:Hellsterung konzentrierter Loungen aus verdunnten durch blosse Membranwirkung. Ein Modelversuch zur Funktion der Niere. Hoppe-Seyler Z. Physiol. Chem. 276:145, 1942.

• 4) Kritz, W. & Lever, A. F.:Renal countercurrent mechanisms:structure and function. Am. Heart J. 78:101, 1969.

• 5) Wirz, H.:Der osmotische Druck des Blutes in der Nierenpapilla. Helv. Physiol. Acta 11:20, 1953.
  pubmed

• 6) Gotschalk, C. W. & Mylle, M.:Micropuncture study of the mammalian urinary concentrating mechanism:evidence for the countercurrent hypothesis. Am. J. Physiol. 196:927, 1959.

• 7) Gottschalk, C. W., Lassiter, W. E., Mylle, M., Ullrich, K. J., Schmidt. Nielsen, B., O'dell, R., & Pehling, G.:Micropuncture study of composition of loop of Henle fluid in desert rodents. Am. J. Physiol. 204:532. 1963.

• 8) Jamison, R. L, Bennet, C. M., & Berliner, R. W.:Countercurrent multiplication by the thin loops of Henle. Am. J. Physiol. 212:357, 1967.

• 9) Jamison, R. L.:Micropuncture study of segments of thin loop of Henle in the rat. Am. J. Physiol. 215:236, 1968.
  pubmed

• 10) Hilger, H. H., Klumper, J. D. & Ullrich, K. J.:Wasserruckresorption und Ionentransport durch die Sammelrohrzellen der Saugetierniere (mikroanalytische Untersuchungen). Pflugers Arch. 267:218, 1958.
  pubmed

• 11) Marsh, D. J.:Solute and water flows in thin limb of Henle's loop in the hamster kidney. Am, J. Physiol. 218:824, 1970.

• 12) Pennel, J. P., Lacy, F. B., & Jamison, R. L.:An in vitro study of the concentrating process in the descending limb of Henle's loop. Kidney Int. 5:337, 1974.

• 13) de Rouffignac, C., & Morel, F.:Micropuncture study of water, electrolyte and urea movements along the loops of Henle in Psam. momys. J. Clin. Invest. 48:474, 1969.

• 14) Jamison, R. L., Roinel, N., & de Roffignac, C,:Urinary concentrating mechanism in the desert rodent Psammomys obesus. Am. J. Physiol. 236:F448, 1979.

• 15) Kokko, J. P.:Sodium and water transport in the descending limb of Henle. J. Clin. Invest. 49:1838, 1970.

• 16) Kokko, J. P.:Urea transport in the proximal tubule and the descending limb of Henle. J. Clin. Invest. 51:1999, 1972.

• 17) Stoner, L. C. & Roch-Ramel, F.:The effects of pressure on the water permeability of the descending limb of Henle's loop of rabbit. Pflugers Arch, 382:7, 1979.

• 18) Niesel, W., & Roskenbleck, H.:MOglichkeiten der konzentrierung von Stoffen in biologischen Gegenstromsystem. Pflugers Arch. 276:555, 1963.

• 19) Marumo, F., Yoshikawa, Y., & Koshikawa, S:Astudy on the concentration mechanism of the renal medulla by mathematical model. Circul. J. 31:1309, 1967.

• 20) Kokko, J. P. & Rector, F. C.,:Countercurrent multiplication system without active transport in renahnnermedulla. Kidney Int. 2:214, Jpn. 1972.

• 21) Imai, M., & Kokko, J. , P.:NaCl, urea and water transport in the thin ascending limb of Henle:generation of osmotic gradients by passive diffusion of solutes. J. Clin. Invest. 53:393, 1974.
  pubmed

• 22) Imai, M. & Kokko, J. P.:Mechanism of sodium and chloride trans port in the thin ascending limb of Henle. J. Clin. Invest. 58:1054, 1976.

• 23) Imai, M,:Function of the thin ascending limb of Henle of rats and hamsters perfused in vitro. Am. J. Physiol. 232:F201, 1977.
  pubmed

• 24) Johnston, P. A., Batillana, C. A., Lacy, F. B., & Jamison, R. L.:Evidence for a concentration gradient favoring outward movement of sodium from the thin loop of Henle. J. Clin. Invest. 59:234, 1977.

• 25) Gelbart, D. R., Battilana, C. A., Bhattacharya, J., Lacy, F. B. & Jamison, R. L.:Transepithelial gradient and fractional delivery of chloride in the thin loop of Henle. Am. J. Physiol 235:F129, 1978.

• 26) Hogg, R. J. & Kokko, J. P.:Comparison between the electrical potential profile and the chloride gradients in the thin limbs of Henle's loop in rats. Kidney Int, 14:428, 1978.
  pubmed

• 27) Marsh, D. J. & Azen, S. P.:Mechanism of NaCl absorption by hamster thin ascending limb of Henle's loop. Am. J. Physiol. 228:71 1975.

• 28) Stephenson, J. L.:Concentration of urine in a central core model of the renal counterflow system. Kidney Int. 2:85, 1972.

• 29) Stephenson, J. L.:Countercurrent transport in the kidney. Ann. Rev. Biophys. Bioeng. 7:315, 1978.

• 30) Stewart, J. & Valtin, H:Computer Simulation of osmotic gradient without active transport in renal inner medulla. Kidney Int. 2:264, 1972.
  pubmed

• 31) 丸茂文昭:腎髄質における尿濃縮機構のコンピュータ・シミュレーション, 北里医学6, 293, 1976.

• 32) Foster, D. M., & Jaquez, J. A.:Comparison using central core model of the renal medulla of the rabbit and rat. Am. J. Physiol. 234:F402, 1978.

• 33) Moore, L. C. & Marsh, D. J.:How descending limb of Henle's loop permeability effects hypertonic urine formation. Am. J. Physiol. 239:F57, 1980.
  pubmed

• 34) Bonventre, J. V. & Lechene, C.:Renal medullary concentrating process:an integrative hypothesis. Am. J. Physiol. 239:F578, 1980.
  pubmed

P.77 掲載の参考文献

• 1) De Wardner, H. E., Mills, I. H., et al.:Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin. Sci. 21:249, 1961.

• 2) 杉野信博:Na排泄因子, 代謝, 13:1463, 1976.

• 3) 杉野信博:Na代謝の動向, 腎と透析, 7:11, 1979.

• 4) 杉野信博:腎不全におけるtrade-off仮説, 代謝Vol.17,No.11,眼で見るページ200, 1980,

• 5) Kuchel, O., Buu, N. T. et al.:Dopamine-sodium relationship, Contrib Nephrol 13:27, 1978.
  pubmed

• 6) Altsheler, P., Klahr, S. et al.:Effects of inhibitors of prostaglandin synthesis on renal sodium excretion in normal dogs and dogs with decreased renal mass. Amer. J. Physiol. 235:F338, 1978.
  pubmed

• 7) Tannenbaum, J., Splawinski, J. A. et al.:Enhanced renal prostaglandin production in the dog. Circul. Res. 36:197, 1975

• 8) Stokes, J. B., Kokko, J. P.:Inhibition of sodium transport by prostaglandin E2 across the isolated, perfused rabbit collecting tubule. J. Clin. Invest. 59:1099, 1977.
  pubmed

• 9) Iino, M., Imai, M.:Effects of prostaglandins on Na transport in isolated collecting tubules. Pflugers Arch. 373:126, 1978.

• 10) Fine, L. G., Trizna, W.:Influence of prostaglandins on sodium transport in isolated medullary nephron segments. Amer. J. Physiol 232:F544, 1977.

• 11) Nasjletti, A., McGiff. J, C., et al.:Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Circul. Res. 43:799, 1978.

• 12) Fitzgibbons, J. P., Gennari, F. J. et al.:Dependence of saline-induced natriuresis upon exposure of the kidney to the physical effects of extracellular fluid volume expansion. J. Clin. Invest. 54:1428, 1974.

• 13) Klemmer, P. J., de los Santos, C. et al.:Saline-induced natriuresis in the dog without prior exposure of the kidney to the physical effects of expansion of the extracellular fluid compartment, Clin. Sci. Mol. Med. 54:525, 1978.

• 14) Bourgoignie, J. J., Hwang, K. H. et al.:The presence of a natriuretic factor in urine of patients with chronic uremia. J. Clin. Invest. 53:1559, 1974.
  pubmed

• 15) Kaplan, M. A., Bourgoignie, J., et al.:The effects of the natriuretic factor from uremic urine on the sodium transport, water and electrolyte content, and pyruvate oxidation by the isolated toad bladder J. Clin. Invest. 53:1568, 1974.
  pubmed

• 16) 本田尚文:Rat腎近位尿細管のNa再吸収に関する研究, 日腎誌15:663, 1973.

• 17) Bourgoignie, J. J., Pennell, J. et al.:Sodium metabolism and volume regulation. p. 1-35, Current Nephrology, Vol. 3 (Editor:Gonick, H. C.) 1979, HMPP (Boston).

• 18) Kramer, H. J.:Antinatriferic and natriuretic activities in human Plasma following acute and chronic salt-loading p. 24-34 Natriuretic hormone (Editors:Kramer, H. J. & Kruck, F.) 1978, Springer-Verlag (Berlin).

• 19) Bricker, N. S., DeWardener, H.:Natriuretic hormone and the control of extracellular fluid volume p. 647-650 Proceed. of 7th International Congress of Nephrol. 1978 Montreal, Canada.

P.86 掲載の参考文献

• 1) Tigerstedt, R., Bergman, P. G.:Niere und Kreislauf. Scand. Arch. Physiol. 8:223, 1898.

• 2) Goldblatt, H. J., Lynch, R. F., Hanzal, R. F. et al.:Studies on experimental hypertension. Production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 59:347, 1934.

• 3) Page, I. H.:On the nature of the pressor action of renin. J. Exp. Med. 70:521, 1939.
  pubmed

• 4) Braun-Menendez, E., Fasciolo, J. C., Leloir, L. F. et al.:La substancia hipertensora de la sangre del rinon isquemiado. Rev. Soc. Argent. Biol. 15:420, 1939.

• 5) Simpson, S. A., Tait, J. F., Wettstein, A. et al.:Isolieurung eines neuen Kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineralstoffwechsel. Experientia 9:333, 1953.
  pubmed

• 6) Laragh, J. H., Angers, M., Kelly, W. G. et al.:Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II and others on the secretory rate of aldosterone in man. J.A.M.A. 174:234, 1960.

• 7) Erdos, E. G.:Angiotensin I converting enzyme. Circ. Res. 36:247, 1975.
  pubmed

• 8) Slater, E. E., Cohn, R. C., Dzau, V. J. et al.:Purification of human renin. Clin. Sci. Mol. Med. 55:117s, 1978.

• 9) Galen, F. X., Guyemme, T. T., Deraux, C. et al.:Direct radio-immunoassay of human renin. J. Clin. Endocrinol, Metab. 48:1041, 1979.

• 10) Peach, M. J.:Renin-angiotensin system:biochemistry and mechanisms of action. Physiol. Rev. 57:313, 1977.
  pubmed

• 11) Laragh, J. H., Sealey, J. E.:The renin-angiotensin-aldosterone hormonal system and regulation of sodium, potassium, and blood pressure homeostasis. In Handbook of physiology ed. by Orloff, J., Berliner, R. W. American Physiological Soclety, Washington D. C., p 831-908, 1973

• 12) Oparil, S., Low, J., Koerner, T. J.:Altered angiotensin-I-conversion in pulmonary disease. Clin. Sci. Mol. Med. 51:537, 1976.
  pubmed

• 13) Ondetti, M. A., Williams, N J., Sabo, E. F. et al.:Angiotensin converting enzyme inhibitors from the venom of Bothrops jararaca:isolation, elucidation of structure, and synthesis. Biochemistry 10:4033, 197I.

• 14) Ondetti, M. A., Rubin, B., Cushman, D. N.:Design of specific inhibitor of angiotensin converting enzyme:new class of orally active antihypertensive agents. Science 196:441, 1977.

• 15) Ferrario, C. M., Gildenberg, P. L, McCubbin, J. W.:Cardiovascular effects of angiotensin mediated by the central nervous system. Circ. Res. 30:257, 1972.
  pubmed

• 16) Cowley, A. W., McCaa, R. E.:Acute and chronic dose-response relationship for angiotensin, aldosterone, and arterial pressure at varying levels of sodium intake. Circ. Res. 39:788, 1976.
  pubmed

• 17) Brown, J. J., Peart, W. S.:The effect of angiotensin on urine flow and electrolyte excretion in hypertensive patients. Clin. Sci. 22:1, 1962.
  pubmed

• 18) McGiff, J. C., Crowshow, K., Terragno, N. A. et al.:Release of a prostaglandin like substance into renal venous blood in response to angiotensin II Circ. Res. 26 (Suppl I):121, 1970.

• 19) Geller, R. G., Margolius, H. S., Pisano, J. J. et al.. Effects mineralocorticoids, altered sodium intake and adrenalectomy urinary kallikrein in rats. Circ. Res. 31:857, 1972.
  pubmed

• 20) Keil, L. C., Summy-Long, J., Severs, W. B.:Release of vasopressin by angiotensin II. Endocrinology 96:1063, 1975.

• 21) Uhlich, E., Weber, P., Eigler, J. et al.:Angiotensin stimulated AVP-release in humans.53:177,1975.
  pubmed

• 22) Blumberg, A., Denny, S., Nishikawa, K. et al.:Angiotensin III:induced prostaglandin (PG) release. Prostaglandins 11:195, 1976.
  pubmed

• 23) Davis, J. O.:What signals the kidney to release renin? Circ. Res. 28:301, 1971.
  pubmed

• 24) Davis, J. O., Freeman, R. H.:Mechanisms regulating renin release. Physiol. Rev. 56:2, 1976.

• 25) Pettinger, W. A., Keeton, T. K, Campbell, W. B. et al.:Evidence for a renal and adrenergic receptor inhibiting renin release. Circ. Res. 38:338, 1976.
  pubmed

• 26) Naftilan, A. J., Oparil, S.:Inhibition of renin release from rat kidney slices by the angiotensins. Am. J. Physiol. 235:F62, 1978.
  pubmed

• 27) Kotchen, T. A., Galla, J. H., Luke, R. G.:Contribution of chloride to the inhibition of plasma renin by sodium chloride in the rat. Kidney Int. 13:201, 1978.

• 28) Schambelan, M., Stockigt, J. R.:Pathophysiology of the renin-angiotensin system. In Handbook of Hormonal Function and the Kidney ed. by Brenner, B. M., Stein, J. H. Churchill Livingstone Inc. New York, p 1-39, 1979.

• 29) Douglas, J., Catt, K. J.:Regulation of angiotensin II receptors in the rat adrenal cortex by dietary electrolytes. J. Clin. Invest. 58:834, 1976.
  pubmed

• 30) Bengis, R. G., Coleman, T. G., Young, D. B. et al.:Long term blockade of angiotensin formation in various normotensive and hypertensive rat models using converting enzyme inhibitor (SQ 14, 225). Circ. Res. (Suppl I) 43:45, 1978.

• 31) Sealey, J. E., Gerten-Banes, J., Laragh, J. H.:The renin system:Variations in man measured by radioimmunoassay or bioassay. Kidney Int. 1:240, 1972.
  pubmed

• 32) Walker, W. G., Moore, M. A., Horvath, J. S. et al.:Arterial and venous angiotensin II in normal subjects:relation to plasma renin activity and plasma aldosterone concentration, and response to posture and volume changes. Circ. Res. 38:477, 1976.
  pubmed

P.93 掲載の参考文献

• 1) Scicli, A. G., Carretero, O. A., Hampton, A., Cortes, P. and Oza, N. B.:Site of kininogenase secretion in the dog nephrone. Am. J. Physiol., 230:533-536, 1976.

• 2) Abe, K.:Urinary excretion of kinin in man with special reference to its origin. Tohoku J. exp. Med., 87:175-184, 1965.
  pubmed

• 3) Scili, A. G., Gandolfi, R. and Carretero, O. A.:Site of formation of kinins in the dog nephrone. Am. J. Physiol., 234:F36-40, 1978.

• 4) Willis, L. R., Ludens, J. H., Hook, J. B. and Williamson, H. E.:Mechanism of natriuretic action of bradykinin. Am. J. Physiol., 217:1-5, 1969.
  pubmed

• 5) Stein, J. H., Congbalay, R. C., Karsh, D. L., Osgood, R. W. and Ferris, T. F.:The effect of bradykinin on proximal tubular sodium reabsorption in the dog. Evidence for functional nephron heterogeneity. J. Clin. Invest., 51:1709-1721, 1972.
  pubmed

• 6) McGiff., J. C., Terragno, N. A., Malik, K. U. and Lonigro, A. J.:Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ. Res., 31:36-43, 1972.
  pubmed

• 7) Furtado, M. R. F.:Inhibition of the permeability response to vasopressin and oxytocin in the toad bladder:Effects of bradykinin, kallidin, eledoisin, and physalaemin. J. Memb. Biol., 4:165-178, 1971.

• 8) Orloff, J., Handler, J. and Bergstram, S.:The effect of prostaglandin (PGE 1) on the permeability response of toad bladder to vasopressin, theophylline and adenosine 3', 5'-monophosphate. Natuer, London, 205:397, 1965.

• 9) McGiff, J. C., Itskovitz, H. D. and Terragno, N. A.:The actions of bradykinin and eledoisin in the canine isolated kidney:relationships to prostaglandins. Clin. Sci. Mol. Med., 49:125-131, 1975.
  pubmed

• 10) Kauker, M. L.:Bradykinin action on the efflux of luminal 22Na in the rat nephron. J. Pharmacol. Exp. Ther., 214:119-123, 1980.
  pubmed

• 11) Nasjletti, A., Colina-Chourio, J. and McGiff, J. C.:Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition. Circ. Rec., 37:59-65, 1975.

• 12) McCaa, R. E., Hall, J. E. and McCaa, C. S.:The effects of angiotensin I-converting enzyme inhibitors on arterial blood pressure and urianry sodium excretion. Role of the renal renin-angiotensin and kallikrein-kinin systems. Circ. Res., 43 (suppl. I):32-39, 1978.

• 13) Kramer, H. J., Moch, T., von Sicherer, L. and Dusing, R.:Effects of aprotinin on renal function and urinary prostaglandin excretion in conscious rats after acute salt loading. Clin. Sci., 56:547-553, 1979.
  pubmed

• 14) Marin-Grez, M.:The influence of antibodies against bradykinin on isotonic saline diuresis in the rat. Evidence for kinin involvement in renal function. Pflugers Arch., 350:231-239, 1974.

• 15) Adetuyibi, A. and Mills, I.. H.:Relation between urinary kallikrein and renal function, hypertension, and excretion of sodium and water in man. Lencet, II:203-207, 1972.

• 16) Margolius, H. S., Horwitz, D., Geller, R. G., Alexander, R. W., Gill, J. R. Jr., Pisano, J. J. and Keiser, H. R.:Urinary kallikrein excretion in normal man.:Relationships to sodium intake and sodium-retaining steroids. Circ. Res., 35:812-819, 1978.

• 17) Levy, S. B., Frigon, R. P. and Stone, R. A.:The relationship of urinary kallikrein activity to renal salt and water excretion. Clin. Sci. Mol. Med., 54:39-45, 1978.
  pubmed

• 18) Margolius, H. S., Geller, R. G., deJong, W., Pisano, J. J. and Sjoerdsma, A.:Altered urinary kallikrein excretion in rats with hypertension. Circ. Res., 30:358-362, 1972.

• 19) Mills, I.. H. and Ward, P. E.:The relationship between kallikrein and water excretion and the conditional relationship between kallikrein and sodium excreiton. J. Physiol., London, 246:695-707, 1975.

• 20) Mills, I.. H., Macfarlane, N. A. A., Ward, P. E. and Obika, L. F. O.:The renal kallikrein-kinin system and the regulation of salt and water excretion. Fed. Proc., 35:181-188, 1976.

• 21) Marin-Grez, M., Cottone, P. and Carretero, O. A.:Evidence for an involvement of kinins in regulation of sodium excretion. Am. J. Physiol., 223:794-796, 1972.
  pubmed

• 22) Epstein, M., Stone, R. A., DeNunzio, A. G. and Frigon, R. P.:Relationship between urinary kallikrein and renal sodium handling during water immersion in normal man. J. Clin. Endocrinol. Metab., 50:122-127, 1980.

• 23) Abe, K., Seino, M., Sakurai, Y., Irokawa, N., Miyazaki, S., Yasujima, M., Chiba, S., Saito, K., Otsuka, Y. and Yoshinaga, K.:Studies on urinary kallikrein and kinin in essential hypertension. In:Kininogenases Kallikrein, 4th Symposium on Physiological Properties and Pharmacological Rationale, Haberland, G. L., Rohen, J. W. and Suzuki, T. (eds), pp.351-364. Stuttgart:Germany. F. K. Schattauer Verlag, 1977.

• 24) Geller, R. G., Margolius, H. S., Pisano, J. J. and Keiser, H. R.:Effects of mineralocorticoids, altered sodium intake and adrenalectomy on urinary kallikrein in rats. Circ. Res., 31:857-861, 1972.
  pubmed

• 25) Johnston, C. I., Matthews, P. G. and Dax, E.:Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats. Clin. Sci. Mol. Med., 51:283s-286s, 1976.

• 26) Nishimura, K., Ward, P. and Erdos, E. G.:Kallikrein and renin in the membrane fractions of the rat kidney. Hypertension, 2:538-545, 1980.
  pubmed

• 27) Kaizu, T. and Margolius, H. S.:Studies on rat renal cortical cell kallikrein. I. Separation and measurement. Biochem. Biophys. Acta, 411:305-315, 1975.
  pubmed

• 28) Horwitz, D., Margolius, H. S. and Keiser, H. R.:Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. J. Clin. Endocrinol. Metab., 47:296-299, 1978.

• 29) Marin-Grez, M., Oza, N. B. and Carretero, O. A.:The involvement of urinary kallikrein in the renal escape from the sodium retaining effect of minerabocorticoids. Henry Ford Hosp. Med. J., 21:85. 90, (1973).

• 30) Nasjletti, A., McGiff, J. C. and Colina-Chourio, J.:Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat:Influence of mineralocorticoids. Circ. Res., 43:799-807, 1978.
  pubmed

P.100 掲載の参考文献

• 1) Hassid, A., Dunn, M. J.:Microsomal prostaglandin biosynthesis of human kidney. J. Biol. Chem., 255:2472-2475, 1980.

• 2) Zusman, R. M., Keiser, H. R.:Regulation of prostaglandin E2 synthesis by angiotensin II, potassium, osmolality, and dexamethasone. Kidney. Intern., 17:277-283, 1980.

• 3) Flower, R. J.:Drugs which inhibit prostaglandin biosynthesis. Pharmacol. Rev., 26:33-67, 1974.
  pubmed

• 4) Hassid, A., Konieczkowski, M., Dunn, M. J.:Prostaglandin synthesis in isolated rat kidney glomeruli. Proc. Natl. Acad. Sci. USA., 76:1155-1159, 1979.
  pubmed

• 5) Williams, W. M., Frolich, J. C., Nies, A. S., Oates, J. A.:Urinary prostaglandins. Kidney. Intern., 11:256-260, 1977.

• 6) Swain, J. A., Heyndrickx, G. R., Boettcher, D. H., Vatner, S. F.:Prostaglandin control of renal circulation in the unanesthetized dog and baboon. Am. J. Physiol., 229:826-830, 1975.
  pubmed

• 7) Donker, A. J. M., Arisz, L., Brentjens, J. R. H., van der Hem, G. K, Hollemans, H. J. G.:The effect of indomethacin on kidney function and plasma renin activity in man. Nephron., 17:288-296, 1976.

• 8) Terrango, N. A., Terrango, D. A., McGiff, J. C.:Contribution of prostaglandins to the renal circulation in conscious, anesthetized, and laparotomized dog. Cir. Res., 40:590-595, 1977.

• 9) Oliver, J. A., Pinto, J., Sciacca, R. R., Cannon, P. J.:Increased renal secretion of norepinephrine and prostaglandin E 2 during sodium depletion in the dog. J. Clin. Invest., 66:748-756, 1980.

• 10) Bolger, P. M., Eisner, G. M., Ramwell, P. W., Slotkoff, L. M.:Renal action of prostacyclin. Nature., 271:467-469, 1978.
  pubmed

• 11) Yarger, W, E., Schocken, D. D., Harris, R. H.:Obstructive nephropathy in the rat. J. Clin. Invest., 65:400-412, 1980.

• 12) Higashihara, E., Stokes, J. B., Kokko, J. P., Campbell, W. B., DuBose, T. D.:Cortical and papillary micropuncture examination of chloride transport in segments of the rat kidney during inhibition of prostaglandin synthesis. J. Clin. Invest., 64:1277-1287, 1979.
  pubmed

• 13)Henrich, W. L., Anderson, R.J, Berns, A. S., McDonald, K. M., Paulsen, P. J., Berl, T., Schrier, R. W.:The role of renal nerves and prostaglandins in control of renal hemodynamics and plasma renin activity during hypotensive hemorrhage in the dog. J. Clin. Invest., 61:744-750, 1978.
  pubmed

• 14) Zipser, R. D., Hoefs, J. C., Speckart, P. F., Zia, P. K., Horton, R.:Prostaglandins.:Modulators of renal function and pressor resistance in chronic liver desease. J. Clin. Endocrinol. Metab., 48:895-900, 1979.

• 15) Kimberly, R. P., Gill, J. R., Bowden, R. E., Keiser, H. R, Plotz, P, H.:Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus. Ann. Int. Med. 89:336-341, 1978.
  pubmed

• 16) Orloff, J., Handler, J. S., Bergstrom, S.:Effect of prostaglandin (PGE1) on the permeability response of toad bladder to vasopressin, theophylline and adenosine 3' 5'-monophosphate. Nature. 205:395-398, 1965.

• 17) Stokes, J. B., Kokko, J. P.:Inhibition of sodium transport by prostaglandin E2 across the isolated, perfused rabbit collecting tubule. J. Clin. Invest. 59:1099-1104, 1977.
  pubmed

• 18) 東原英二:水代謝と腎プロスタグランディン 日医誌 84:389-394, 1980.

• 19) Stoff, J. S., Silva, P., Rosa, R., Epstein, F. H.:Effect of indomethacin on water excretion in diabetes incipidus. Abstracts, H inter. national congress of nephrology. Q-2., 1978.

• 20) Vander, A. J.:Direct effects of prostaglandin on renal function and renin release in anesthetized dog. Am. J. Physiol., 214:218-221, 1968.
  pubmed

• 21) Tannenbaum, J., Splawinski, J. A., Oates, J. A., Nies, A. S.:Enhanced renal prostaglandin production in the dog. Circ. Res., 36:197-203, 1975.
  pubmed

• 22) Stokes, J. B.:Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. J. Clin. Invest. 64:495 502 1979.

• 23) Kauker, M. L.:Prostaglandin E2 effect from luminal side on renal tubular 22Na efflux. Proc. Soc. Exp. Biol. Med., 154:274-277, 1977.
  pubmed

• 24) Brodie, B. B., Lowman, E. W., Burns, J. J., Lee, P. R., Chenkin, T., Goldman, A., Weiner, M., Steele, M.:Observations on the antirheumatic and physiologic effects of phenylbutazone and some comparisons with cortisone. Am. J. Med., 16:181-190, 1954.

• 25) Feldman, D., Loose, D. S., Tan, S. Y.:Nonsteroidal anti-inflammatory drugs cause sodium and water retension in the rat. Am. J. Physiol., 234:F490-F496, 1978.

• 26) Gagnon, J. A., Felipe, I.:Effect of prostaglandin synthetase inhibition on renal sodium excretion in the water. loaded conscious and anesthetized dog. Miner. Electrolyte. Metabol., 2:293-301, 1979.

• 27) Kover, G., Tost, H.:The effect of indomethacin on kidney function. Pflugers. Archiv., 372:215-220, 1977.
  pubmed

• 28) Oliw, E., Kover, G., Larsson, C., Anggard, E.:Indomethacin and diclofenac sodium increase sodium and water excretion after extracellular volume expansion in the rabbit. European. J. Pharmacol., 49:381-388, 1978.

• 29) Hockel, G. M., Cowley, A. W.:Effect of chronic intrarenal prostaglandin E2 infusion and angiotensin I blockade on arterial pressure in the dog. Advances in prostaglandin and thromboxane research., 7:1061-1065, 1980.

• 30) Schnermann, J., Schubert, G., Hermle, M, Herbst, R., Stowe, N. T., Yarimizu, S., Weber, P. C.:The effect of inhibition of prostaglandin synthesis on tubuloglomerular feedback in the rat kidney. Pflugers. Archiv., 379:269-279, 1979.
  pubmed

P.109 掲載の参考文献

• 1) Goldberg, L. I., Talley, R. C. & McNay, J. L.:The potential role of Dopamine in the treatment of shock, Progr. Cardiovasc. Dis. 12:40, 1969.

• 2) Black, W. L. & Rolett, E, L.:Dopamine-induced alterations in left ventricular performance, Circ. Res. 19:71, 1966.

• 3) 山田崇之, 平沼進, 竹村克二, 十九浦敏男, 浅野献一:Dopamine血行動態に及ぼす影響, 開心術後急性期症例における検討, 麻酔 26:1511, 1977.

• 4) Harrisson, D. C. Pirages, S., Robinson, S. C. & Wintroub, B. U.:The pulmonary and systemic circulatory response to dopamine infusion, Br. J. Pharmac. 37:618, 1969.

• 5) 戸田昇, 藤原元始:ドーパミンと心血管系, 代謝 10:201, 1973.

• 6) 十九浦敏男, 山田崇之, 浅野献一, 平沼進, 竹村克二:開心術後管理におけるDopamineの応用, 特に腎機能に及ぼす影響について, ICUとCCU 3 :19, 1979.

• 7) 小島至, 水越洋:カテコールアミンとNa代謝, Na利尿ホルモンとしてのDopamine, 日本臨床 37:310, 1979.
  Medical*Online

• 8) Ramdohr, B., Biamino, G. & Schroder, R.:Vergleichende Untersuchungen uber die Wirkung von Dopamine und Orciprenalin am gesunden Menschen, Klin. Wschr. 50:149, 1972.

• 9) Bevilacqua, M., Norbiato, G., Raggi, U., Micossi, P., Baggio, E. & Prandelli, M.:Dopaminergiccontrol of serum potassium, Metabolism 29:306, 1980.
  pubmed

• 10) Bagwell, E. E. & Daniel, H. B.:Comparative effects of dopamine and norepinephrine on myocardial function and metabolism during experimental cardiogenic shock, J. Pharm. Exp, Therap. 173:357, 1970.

• 11) Ramdohr, B., Schuren, K. P., Biamino, G. & Schroder, R.:Der Einfluss von Dopamin auf Hamodynamik and Nierenfunktion bei derschweren Herzinsuffizienz des Menschen, Klin. Wschr. 51:549, 1973.
  pubmed

• 12) Goldberger, E.:Treatment of Cardiac Emergencies, 2nd Edit., C. V. Mosby Co., Saint Louis, 1977, p. 315.

P.124 掲載の参考文献

• 1) Parfitt, A. M., Kleerekoper, M.:The divalent ion homeostatic system-physiology and metabolism of calcium, phosphorus, magnesium and bone. Edited by Maxwell, M. H., Kleeman, C. R. Clinical disorders of fluid and electrolyte metabolism. M raw-Hill, C,. Y 1980, p. 269-398

• 2) Brighurst, F. R., Potts, J. T.:Calcium and phosphate distribution turnover and metabolic action. Edited by DeGroot. L. G. et al Endocrinology, Vol. 2, Grun & Stratton, N. Y. 1979, p. 621-629.

• 3) Mayer, G. P.:Parathyroid hormone secretin. ibid., p. 607-611.

• 4) Parson, J. A.:Physiology of parathyroid hormone:ibid., p. 621-629.

• 5) Habener, J. F., Potts, J. T.:Biosynthesis of parathyroid hormone (I), New Engl. J. Med. 299:580-585, 1978.
  pubmed

• 6) Habener, J. F., Potts, J. T.:Biosynthesis of parathyroid hormone (II) New Engl. J. Med. 299:635-644, 1978.

• 7) Martin, K. J., Hruska, K. A., Freitag, J. J., Klahr, S., Slatopolsky, E. et al.:The peripheral metabolism of parathyroid hormone. New Engl. J. Med. 302:1092-1097, 1979.

• 8) Slatopolsky, E., Martin, K., Hruska, K.:Parathyroid hormone meta. bolism and its potential as a uremic toxin. Am. J. Physiol. 239:F1-F2, 1980.

• 9) 岡野一年:鉱質と副甲状腺ホルモン, 藤田拓男編, 鉱質病, 南江堂, 東京, 1980, p. 73-92.

• 10) Charbardes. D. Imbert, M., Clique, A., et al.:PTH sensitive adenyl cyclase activity in different segments of the rabbits nephron. Pflugers Arch. 354:229-239, 1975.

• 11) Morel, F., Charbardes, D., Imbert, M., et al.:Functional segmentation of the rabbit distal tubule by microdetermination of hormone. Kidney Internat. 9:264-277, 1976.

• 12) Ichikawa, L, Humes, H. D., Dousa, T. P. et al.:Influence of parathyroid hormone on glomerular ultrafiltration in the rat. Am. J. Physiol. 234:F393-401, 1978.

• 13) 吉田薫, 浅野泰, 今井正:副甲状腺ホルモンと腎, 腎と透析 8:677-689, 1980.

• 14) 須田立雄:活性型ビタミンDの研究に関する最近の進歩, 第一回関東 α-D3 研究会報告集, 中外製薬株, 東京, 1978, p 1-20.

• 15) 大沼規男, 橋本喜信:ビタミンD研究の最近の進歩, 腎と透析 10:27-32, 1981.

• 16) 尾形悦郎, 板倉光夫:カルシウム代謝, リン代謝, 上田英雄他編, 内科学, 朝倉書店, 東京, p. 850-852, 1980.

• 17) 尾形悦郎, 腎臓と副甲状腺, 第一回関東α-D3研究会報告集, 中外製薬, 東京, p. 21-41, 1978.

• 18) Bricker, N. S.:On the pathogenesis of the uremic state:an exposition of the trade-off hypothesis. New Engl. J. Med. 286, 1093, 1972.
  pubmed

• 19) Slatopolsky, E., Rutherford, W. Z. et al.:How important is phosphate in the pathogenesis of renal osteodystrophy? Arch. Int. Med. 138:848, 1978.

• 20) Massry, S. G., Ritz, E.:The pathogenesis of secondary hyperparathyroidism of renal failure. Arch. Int. Med. 138, 853, 1978.

• 21) Reiss, E. et al.:Circulating parathyroid hormone concentration in chronic renal insufficiency, Arch. Int. Med. 124:417, 1969.

• 22) Arnaud, C. D.:Hyperparathyroidism and renal failure. Kidney, Internat. 4:89, 1973.

• 23) 小椋陽介:腎不全におけるビタミンD代謝異常, 腎と透析 10:33-38, 1981.

4. 病態生理と診断検査法

P.133 掲載の参考文献

• 1) Schrier, R. W. & Humphreys, M. H., Circ. Res. 29:479, 1971.
  pubmed

• 2) Katz, M. A., New Engl. J. Med. 289:843, 1973.
  pubmed

• 3) Roscoe, J. M. et al., Canad. Med. J. 112:452, 1975.

• 4) 和田孝雄, 浮腫, 新内科学大系, 循環器Ib, p. 91, 中山書店, 1978.

P.144 掲載の参考文献

• 1) Kunau, R. T., Jr., & Stein, J. H.:Disorders of potassium metabolism. In:Strauss and Welt's Diseases of the Kidney, edited by Earley, L. E., and Gottschalk, C. W., Vol. II, p. 1581, Little, Brown and Co., Boston, 1979.

• 2) Knochel, J. P.:Role of glucoregulatory hormones in potassium homeostasis. Kidney Int. 11:443, 1977.
  pubmed

• 3) Silva, P., Brown, R. S., & Epstein, F. H.:Adaptation to potassium. Kidney Int. 11:466, 1977.
  pubmed

• 4) D:Silva, J. L.:The action of adrenaline on serum potassium. J. Physiol. (London) 82:393, 1934.
  pubmed

• 5) Alexander, E. A., & Levinsky, N. G.:An extrarenal mechanism of potassium adaptation. J. Clin. Invest. 47:740, 1968.
  pubmed

• 6) Fraley, D. S., & Adler, S.:Isohydric regulation of the plasma potassium by bicarbonate in the rat. Kidney Int. 9:333, 1976.
  pubmed

• 7) Wright, F. S.:Sites and mechanisms of potassium transport a-long the renal tubule. Kidney Int. 11:415, 1977.
  pubmed

• 8) Jamison, R. L., Lacy, F. B., Pennell, J. P., & Sanjana, V. M.:Potassium secretion by the descending limb or pars recta of the juxtamedullary nephron in vivo. Kidney Int. 9:323, 1976.
  pubmed

• 9) Grantham, J. J., Qualizza, P. B., & Irwin, R. L.:Net fluid secretion in proximal straight tubules in vitro. Am. J. Physiol. 226:191, 1974.
  pubmed

• 10) Rocha, A. S., & Kokko, J. P.:Membrane characteristics regulating potassium transport out of the isolated perfused descending limb of Henle. Kidney Int. 4:326, 1973.
  pubmed

• 11) Giebisch, G.:Renal potassium excretion. In:The Kidney, edited by Rouiller, C., & Muller, A. F., Vol III, p. 329, Academic Press, New York, 197I.

• 12) Grantham, J. J., Burg, M. B., & Orloff, J.:The nature of the transtubular Na and K transport in rabbit collecting tubules. J. Clin. Invest. 49:1815, 1970.

• 13) Diezizi, J., Michoud, P., Aceves, J., & Giebisch, G.:Micropuncture study of electrolyte transport across papillary collecting duct of the rat. Am. J. Physiol. 224:623, 1973.
  pubmed

• 14) Jamison, R. L.:Micropuncture of superficial and juxtamedullary nephrons in the rat. Am. J. Physiol. 218:46, 1970.
  pubmed

• 15) Conn, J. W.:Primary aldosteronism:A new clinical syndrome. J. Lab. Clin. Med. 45:6, 1955.

• 16) Christy, N. P., & Laragh, J. H.:Pathogenesis of hypokalemic alkalosis in Cushing's syndrome. N. Engl. J. Med. 265:1083, 1961.
  pubmed

• 17) Robertson, T. W., Klidjian, A., Harding, L. K., Walters, G., Lee, M. R., & Robb-Smith, A. H. T.:Hypertension due to a renin secreting renal tumor. Am. J. Med. 43:963, 1967.

• 18) Kihara, I., Kitamura, S., Hoshino, T., Hitoshi, S., & Watanabe, T. A.:Hitherto unreported vascular tumor of the kidney:A proposal of juxtaglomerular cell tumor. Acta Pathol. Jap. 18:197, 1968.

• 19) Bongiovanni, A. M.:Disorders of adrenal cortical steroid biogenesis. In:The Metabolic Basis of Inherited Disease, edited by Stanbury, J. B., Wyngaarden, J. B., & Fredrickson, D. S., p. 857, McGrow Hill, New York, 1972.

• 20) Biglieri, E. G., Herror, M. A., & Brust, N.:17-hydroxylation deficiency in man. J. Clin, Invest. 45:1946, 1966.

• 21) Conn, J. W., Rovner, D. R., & Cohen, E. L.:Licorice induced pseudoaldosteronism. J. A. M. A. 205:492, 1968.
  pubmed

• 22) Bartter, F. C., Pronove, P., Gill, J. R. Jr., & MacCardle, R. C.:Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am. J. Med. 331811, 1962.

• 23) Erkelens, D. W., & Statius Van Eps, L. W.:Bartter's syndrome and erythrocytosis. Am. J. Med. 55:711, 1973.
  pubmed

• 24) Cannor, P. J., Leeming, J. M., Sommers, S. C., Winters, R. W., & Laragh, J. H.:Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome):A revaluation of the pathophysiology. Medicine (Baltimore) 47:107, 1968.

• 25) Bartter, F. C., Gill, J. R., Frolich, J. C., Bowden, R. E., Hollifield, J. W., Keiser, H. R., Oates, J. A., Seyberth, H., & Taylor, A. A.:Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome. Clin. Res. 24.

• 26) Liddle, G. W., Bledose, T., & Coppage, W. S., Jr.:A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans. Assoc. Am. Physicians 76:199, 1963.

• 27) Sebastian, A., McSherry, E., & Morris, R. C., Jr.:Renal potassium wasting in renal tubular acidosis. J. Clin. Invest. 50:667, 197I.
  pubmed

• 28) Schwartz, W. B., & Kassirer, J. P.:Effects of ureteral transplantation. In:Diseases of the Kidney, edited by Strauss, M. B., & Welt, L. G., 1st ed., p. 759, Little, Brown & Co., Boston, 1963.

• 29) Lipner, H. I., Ruzany, F., Dasgupta, M., Lief, P. D., & Bank, N.:The behavior of carbenicillin as a non-reabsorbable anion. J. Lab. Clin. Med. 86:183, 1975.

• 30) McCurdy, D. K., Frederic, M., & Elkinton, J. R.:Renal tubular acidosis due to amphotericin B. N. Engl. J. Med. 278:124, 1968.
  pubmed

• 31) Muggia, F. M., Heinmann, H. O., Farhangi, M., Osserman, E. O.:Lyzozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia. Am. J. Med. 47:351, 1969.

• 32) Hartmann, R. C., Auditore, J. V., & Jackson, D. P.:Studies on thrombocytosis. I. Hyperkalemia due to release of potassium from platelets during clotting. J. Clin. Invest. 37:699, 1958.
  pubmed

• 33) Schon, D., Silva, P., & Hayslett, J. P.:The mechanism of potassium excretion in chronic renal failure. Am. J. Physiol. 227:1323, 1974.

• 34) Finkelstein, F. O., & Hayslett, J. P.:Role of medullary Na-K-ATPase in renal potassium adaptation. Am. J. Physiol. 229:524, 1975.

• 35) Silva, P., Charney, A. N., & Epstein, F. H.:Potassium adaptation and Nak-ATPase activity in mucosa of colon. Am. J. Physiol. 229:1576, 1975.

• 36) Weidmann, P., Reinhart, R., Maxwell, M. H., Rowe, P., Coburn, J. W., & Massry, S. G.:Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease. J. Clin. Endocr. Metab. 36:965, 1973.
  pubmed

• 37) Iversen, T.:Congenital adrenocortical hyperplasia with disturbed electrolyte regulations:(dysadrenocorticism) . Pediatrics. 16:875, 1955.
  pubmed

• 38) David, R., Golan, S., & Drucker, W.:Familial aldosterone deficiency enzyme defect, diagnosis, and clinical course, Pediatrics, 41:403, 1968.
  pubmed

• 39) Spitzer, A., Edelman, C. M., Jr., Goldberg, L. D., & Henneman, P. H.:Short stature, hyperkalemia and acidosis;adefect in renal transport of potassium. Kidney Int. 3:251, 1973.

• 40) Smith, T. W., & Willerson, J. T.:Suicidal and accidental digitoxin ingestion. Report of five cases with serum digitoxin level correlations. Circulation 44:29, 1971.

• 41) Gamstrop, I.:Adynamia episodica hereditaria. Acta paediat. (Stockholm) 45:Suppl. 108, p. 1, 1956,

• 42) Makoff, D. L, DaSilva, J. A., & Rosenbaum, B. J.:On the mechanism of hyperkalemia due to hyperosmotic expansion with saline or mannitol. Clin. Sci. 41:383, 1971.
  pubmed

• 43) Weinbraub, H. D., Heisterkamp, D. V., & Cooperman, L. H.:Changes in plasma potassium concentration after depolarizing blockers in anesthetized man. Br. J. Anesth. 41:1048, 1969.

• 44) Hertz, P., & Richardson, J. A.:Arginine-induced hyperkalemia in renal failure patients. Arch. Intern. Med. 130:778, 1972.
  pubmed

P.156 掲載の参考文献

• 1) Ad Hoc Committee:Current concepts of acid-base measurment. Ann. New York Acad. Sci 133, 251, 1966.

• 2) 本田良行:酸塩基平衡の基礎と臨床 (基礎篇), 真興交易医書出版部, 東京, 1974.

• 3) Wyman, J.:Heme proteins. Adv. Protein Chem. 4:407-531, 1948.
  pubmed

• 4) Winters, R. W. et al:Acid base physiology in medicine 2nd ed. London Comp., Ohio, 1969.

• 5) Siggaard-Andersen, O.:The acid-base status of the blood. 4th ed. Munksgaard, Copenhagen, 1974.

• 6) Burnett. R. W, and Noonam, D.:Calculations and Correction factors used in determination of blood pH and blood gases. Clin. Chem. 20, 1499, 1974.

• 7) Siggaard-Andersen, O.:An acid-base chart for arterial blood with normal and pathological reference area. Scand. J. Clin. Lab. Invest. 27. 239, 1971.

• 8) Davidsohn, I. and Henry, J. B.:Todd-Sanford clinical diagnosis by laboratory methods. 15th. ed. W. B. Saunders Co., Philadelphia, 1974.

• 9) 須藤睦雄, 本田西男:代謝性・呼吸性アルカロージス. 臨床看護, 5 (7): 1023, 1979.

• 10) 三輪東一郎:代謝性・呼吸性アシドーシス. 臨床看護, 5 (7):1016, 1979.

• 11) 宮崎正夫:ショックの病態生理と臨床. 金原出版, pp. 320-323, 1974.

• 12) 宮崎正夫:酸塩基平衡ハンドブック. 真興交易, 1970, 胸部外科の部, pp. 129-145.

P.173 掲載の参考文献

• 1) Marriott, H. L.:Water and Salt depletion. Brit Med. J. 1:240, 285, 328, 1947.

• 2) Kuhlmann, W. U., and G. Siegenthaler:Wasser und Electrolyt haushalt. In Siegenthaler et al edit, Pathologische Physiologie, G. Thieme. 196-232;1979.

• 3) 佐藤登志郎他:ヘマトクリットによる血奨量算定におよぼす浸透圧の影響, 臨床生理8:632-637, 1978.

• 4) Pappenheimer, J. R., and A. Soto-Rivera:Effective osmotic Pres, sure of the plasma proteins and other quantities associated with the capillary circulation in the hindlimbs of cats and dogs. Am. J. Physiol. 152:471-491, 1948.

• 5) Sato, T. etal:Estimation of Body Water and Salt Contents from plasma Sodium, Protein Concentrations and Hematocrit. Jap. Heart. J. 20:853-866, 1979.
  pubmed

• 6) Talbot, N. B., R. H. Richie, and J. D. Crawford, Metabolic homeostasis:A syllabus for those Concerned with the case of patients, Harvard, Cambridge, Mass. 1959.

• 7) 佐藤登志郎他:体液異常のコンパートメントモデルによる考察医用電子と生体工学 17:69-72, 1979.

• 8) 佐藤登志郎他:体液制御モデルとコンピュータ介助による輸液指針. 医学のあゆみ, 110:828-837, 昭和54.

• 9) Sato, T. et al:Computer assisted Diagnosis and Treatment of Body Fluid Disturbances. Automedica, 383-96, 1980.

• 10) 佐藤登志郎:老年者の輸液管理. 日本臨床, 1981.
  Medical*Online

• 11) 佐藤登志郎:脱水症.綜合臨床. 29:2793-2798, 1980.

P.180 掲載の参考文献

• 1) 藤田拓男:カルシウム代謝とその異常, 裕文社, 1979.

• 2) 藤田拓男編:鉱質病, 南江堂. 1980.

• 3) 藤田拓男編:カルシウムの臨床, 科学評論社, 1979.

• 4) Bijvoet, O. L M.:Kidney function in calcium and phosphorns metabolism. Metabolic Bone Disease. Avioli, L. V. and Krane, S. M., ed. pp. 50-127, Academic Press, 1977.

• 5) Marx, S. J., et al:Divalent cation metabolism. Amer. J. Med. 65:235, 1978.
  pubmed

• 6) Marx, S. J. et al:Familial hypocalciuric hypercalcemia:Recognition among patients referred after unsuccessful parathyroid exploration. Ann. Intern. Med. 92:351, 1980.
  pubmed

• 7) 藤田拓男:副甲状腺ホルモン, 綜合臨牀, 29:2379, 1980.

• 8) Tashjian, A. H. Jr. et al:Immunoassay of human calcitonin. New Engl J. Med. 283:890, 1976.

• 9) Eisman, J. A. et al:A sensitive, precise and convenient method for determination of 1, 25 (OH) 2 vitamin D 3 in human plasma. Arch. Biochem. Biophys. 176:235, 1976.

• 10) 藤田拓男他:骨共振振動法の臨床的応用, 骨代謝, 13:183, 1980.

5. 診断から治療まで

P.191 掲載の参考文献

• 1) Bartter, F. C. et al.:Am. J. Med., 33:811, 1962.
  pubmed

• 1) Conn, J. W.:J. Lab. Clin. Med., 45:3, 1955.
  pubmed

• 2) Biglieri, E. G. et al.:Am. J. Med., 52:623, 1972.
  pubmed

• 2) Verberckmoes, R. et al.:Kidney Int., 9:302, 1976.
  pubmed

• 3) Fichman, M. P. et al.:Am. J. Med., 60:785, 1976.
  pubmed

• 3) Ferriss, J. B. et al.:Am. Heart J., 95:375, 1978.
  pubmed

• 4) 加藤堅一, 他:厚生省特定疾患「ステロイドホルモン産生異常症」調査研究班, 昭和54年度研究報告書 (班長:井林博):13, 1980.

• 4) Gill, J. R. et al.:Am. J. Med., 61:43, 1976.
  pubmed

• 5) 加藤堅一, 他:綜合臨牀, 29:919, 1980.

• 5) Zipser, R. D. et al.:J. Clin. Endocrinol. Metab., 48:895, 1979.
  pubmed

• 6) Gill, J. R. et al.:Am. J. Med., 65:766, 1978.
  pubmed

• 6) Sutherland, D. J. A. et al.:Canad. Med. Assoc. J., 95:1109, 1966.

• 7) Conn, J. W. et al:JAMA, 193:200, 1965.
  pubmed

• 8) 鳥飼龍生:日内会誌, 58:579, 1969.

• 9) Conn, J. W. et al:Arch, Intern. Med., 123:113, 1969.
  pubmed

• 10) Biglieri, et al:JAMA, 201:510, 1967.

• 11) Biglieri, E. G. et al.:Arch. Intern. Med., 126:1004, 1970.
  pubmed

• 12) Kem, D. C. et al.:Arch. Intern. Med., 128:380, 1971.
  pubmed

• 13) Streeten, D. H. P. et al.:Am. J. Med., 67:403, 1979.

• 14) Ganguly, A. et al.:J. Clin. Endocrinol. Metab., 36:401, 1973.
  pubmed

• 15) Biglieri, E. G. et al.:Circ. Res. [Suppl. 1]34, 35:1-183, 1974.

• 16) Wisgerhof, M. et al.:J. Clin. Endocrinol. Metab., 52:195, 1981.
  pubmed

• 17) Wenting, G. J. et al.:J. Clin. Endocrinol. Metab., 46:326, 1978.
  pubmed

• 18) Kem, D. C. et al.:J. Clin. Endocrinol. Metab., 46:552, 1978.
  pubmed

• 19) Kuchel, O. et al.:J. Clin. Endocrinol. Metab., 51:337, 1980.
  pubmed

• 20) Brown, R. D. et al.:Clin. Res., 27:678A, 1979.

• 21) Conn, J. W. et al.:Arch. Inten. Med., 129:417, 1972.

• 22) Fukuchi, S. et al.:Clin. Sci. Mol. Med., 49:187, 1974.

• 23) Ferris, J. B. et al.:Lancet, II:995, 1970.

• 24) Biglieri, E. G. et al.:J. Clin. Endocrinol. Metab., 49:87, 1979.
  pubmed

P.207 掲載の参考文献

• 1) 井林博:最新医学25:534, 1970;診断と治療60:284, 1972;ホルモンと臨床 27 (増刊号):178, 1979;29:639, 1981.

• 2) Guttman, P. H.:Clin. Exp. Immunol. 5:341, 1969;Arch Pathol. 101 742, 1930.

• 3) Nerup, J.:Acta Endocrinol. 76:127, 142, 1974.

• 4) 井林博:日本内分泌学会雑誌54:1314, 1978;臨床科学14:917, 1978.

• 5) 加藤堅一, 井林博:厚生省特定疾患「ステロイドホルモン産生異常症」調査研究班, 昭和54年度研究報告書, p. 13, 1980.

• 6) 井村裕夫:厚生省特定疾患「ホルモン受容体異常症」調査研究班, 昭和52年度研究報告書, p.21,1978;日本内分泌学会雑誌56:1031, 1980;厚生省特定疾患「ステロイドホルモン産生異常症」調査研究班, 昭和54年度研究報告書, p. 267, 1980.

• 7) Codaccioni, G, L. et al:Ann. Endocrinol. 31:879, 1970.

• 8) Thomsen, M. et al:Transplantation Reviews 22:125, 1975.
  pubmed

• 9) 関原久彦:医学のあゆみ116:127, 1981.

• 10) Sorkin, S. Z.:Medicine 28:371, 1949.
  pubmed

• 11) 井村裕夫, 河野剛:「ステロイドホルモン産生異常症」調査研究班, 昭和52年度研究報告書, p. 89, 1978.

• 12) 加藤堅一, 井林博:ホルモンと臨床 28:1441, 1980; 日本内分泌学会雑誌 57:321, 1981.

• 13) 五十嵐良雄:ホルモンと臨床28:727, 1980.

• 14) 諏訪城三:ホルモンと臨床28:731, 1980.

• 15) 神戸川明ほか:ホルモンと臨床28:773, 1980.

• 16) Bongiovanni, A. M. et al:J. Clin. Endocrinol. a. Metabol. 24:1312, 1317, 1964.

• 17) Dupont, B. et al:Lancet 2:1309, 1977;8th International Histocompa-tibility Workshop and Conference, Feb., 1980 (Los Angels)

• 18) Price, D. A. et al:Lancet 1:930, 1978.

• 19) 斎藤喜親ほか:ホルモンと臨床 28:767, 1980.

• 20) 田苗綾子ほか:「ステロイドホルモン産生異常症」調査研究班, 昭和54年度研究報告書, p. 237, 1980.

• 21) 田苗綾子ほか:ホルモンと臨床28:749, 1980.

• 22) 大山建司ほか:ホルモンと臨床28:739, 1980.

• 23) 新美仁男ほか:ホルモンと臨床28:757, 1980.

• 24) Hsu, T.:Ann. Int. Med. 92:628, 1980.
  pubmed

P.215 掲載の参考文献

• 1) Dashe, A. M., et al. l JAMA, 185:699, 1963.

• 2) Miller, M., et al.:Ann. Intern. Med., 73:721, 1970.

• 3) Forrest, J. N., et al.:J. Clin. Invest., 53:1115, 1974.
  pubmed

• 4) Forrest, J. N., Jr. and Singer, I.:In Disturbances in body fluid osmolality ed. by Andreoli, T. E. et al. Amer. Physiol. Soc. p. 309, 1977.

• 5) Hickey, R. C. and Hare, K.:J. Clin. Invest., 23:768, 1944.

• 6) Carter, A. C. and Robbins, J.:J. Clin. Endocrinol., 7:753, 1947.

• 7) 清水倉一:日本臨床, 37:2519, 1979.
  Medical*Online

• 8) Kennedy, G. C. and Crawford, J. D.:Lancet, 1:866, 1959.
  pubmed

• 9) Arduino, E., et al. l J. Clin. Endocr., 26:1325, 1966.

• 10) Braunhofer, J. L. and Zicha, L.:Med. Welt., 36:1875, 1966.

• 11) de Gennes, J. L, et al.:Compt. Rend. Ser. D. 269:2607, 1969.

• 12) Zusman, R. M., et al.:Federation Proc., 36:361, 1977.

• 13) Zusman, R. M., et al.:Federation Proc., 36:2728, 1977.

• 14) Zusman, R. M., et al.:Clin. Res., 25:452 A, 1977.

• 15) 浦壁重治, 白井大禄:内科, 29:1115, 1972.

• 16) 高光義博ほか:内科セミナー「利尿薬」永井書店, p. 222. 1980.

• 17) 折田義正, 高光義博:内科セミナー「分子病I」永井書店, p. 288, 1980.

• 18) Moses, A. M., et al.:J. Clin. Invest., 52:535, 1973.
  pubmed

• 19) Moses, A. M. and Miller, M.:N. Engl. J. Med., 291:1234, 1974.

• 20) Kimura, T., et al.:J. Clin. Endocrinol. Metab., 38:356, 1974.
  pubmed

• 21) Meinders, A. E., et al.:Clin. Sci. Mole. Med., 47:289, 1974.

• 22) Zaoral, M., et al.:Collec. Czech. Chem. Commun. 32:1250, 1967.

• 23) Cort, J. H.:Clin. Invest., 5:165, 1975.
  pubmed

• 24) Sawyer, W. H., et al.:Endocrinology, 95:140, 1974.
  pubmed

• 25) Cort, J. H.:Kidney Int., 8:292, 1975.
  pubmed

• 26) Ward, M. K. and Frazer, T. R.:Br. Med. J. 3:86, 1974.

• 27) 田苗綾子ほか:日内分泌会誌, 54:676, 1978.
  Medical*Online

• 28) Fichman, M., et al.:Fourth International Prostaglandin Conference (Abstr.) Washington D. C., p. 33, 1979.

P.220 掲載の参考文献

• 1) Schwartz, W. B., Bennett, W., Curelop, S. and Bartter, F. C.:A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Amer. J. Med., 23:529, 1957.
  pubmed

• 2) Bartter, F. C., and Schwartz, W. B.:The syndrome of inappropriate secretion of antidiuretic hormone. Amer. J. Med., 42:790, 1967.
  pubmed

• 3) Nolph, K. D. and Schrier, R. W.:Sodium, potassium and water metabolism in the syndrome of inappropriate antidiuretic hormone secretion. Amer. J. Med., 49:534, 1970.
  pubmed

• 4) Baumann, G., Lopez-Amor, E., and Dingman, J. F.:Plasma arginine vasopressin in syndrome of inappropriate antidiuretic hormone secretion. Amer. J. Med., 52:19, 1972.

P.227 掲載の参考文献

• 1) Arieff, A. I., Guisado, R. & Lazarswitz, V. C.:Pathophysiology of hyperosmolar states. I. Disturbances in body fluids. Ed. by Andreoli, T. E., et al., American Physiology Society, Bethesda, Maryland, 1977.

• 2) Ross, E. J. & Christie, S. B. M.:Hypernatremia. Medicine, 48:441, 1959.

• 3) Arieff, A. I. & Carroll, H. J.:Nonketotic hyperosmolar coma with hyperglycemia. Clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of therapy in 37 cases. Medicine, 51:73, 1972.
  pubmed

• 4) Fulop, M., Rosenblatt, A., Kreitzer, M. & Gerstenhaber, B.:Hyperosmolar nature of diabetic coma. Diabetes, 24:594, 1975.

• 5) Alberti, K. G. M. M., Hockaday, T. D. R. & Turner, R. C.:Small doses of intramuscular insulin in the treatment of diabetic coma. Lancet, II:515, 1973.

• 6) Pfeiffer, E. F.:Development and future aspects of an artificial beta cell system. Symposium Capri, Diabetes Research Today. Schattauer, F. K., Verlag, p. 259, 1976.

• 7) 七里元亮, 河盛隆造:インスリン療法の新しい動向. 内科セミナーEND4 糖尿病, 織田, 阿部他編, 永井書店, p. 175, 1978.

• 8) 七里元亮, 河盛隆造, 鮴谷佳知, 村田貞史, 菊池幹雄, 山崎義光, 野村誠. 新居貞雄, 阿部裕:人工膵β細胞による糖尿病性昏睡, ケトーシスの治療-インスリン少量持続注入療法の比較, 糖尿病, 23 (8):235, 1980.

P.233 掲載の参考文献

• 1) Mason, D. T., et al.:Alterations of hemodynamics and myocardial mechanics in patients with congestive heart failure:Pathophysio logic mechanisms and assessment of cardiac function and ventricular contractility. Prog. Cardiovascul. Dis., 12:507, 1970.

• 2) Mason, D. T.:Control of the peripheral circulation in health and disease. Mod. Conc. Cardiovascul. Dis., 36:25, 1967.

• 3) 松本越生:静脈うっ血の腎機能におよぼす影響に関する研究, 日内会誌, 54: 93, 1965.

• 4) Mason, D. T.:Autonomic nervous system and regulation of cardiovascular performance. Anesthesiology, 29:670, 1968.
  pubmed

• 5) Davis, J. O.:The role of the adrenal cortex and kidney in the pathogenesis of cardiac edema. Yale J. Biol. Med., 35:402, 1963.
  pubmed

• 6) Knight, R. K. et al:Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease. Brit. Heart J., 42:316, 1979.
  pubmed

• 7) Sealey, J. E. and Laragh, J. H.:Further studies of a natriuretic substance occuring in human urine and plasma. Circulation Res., 28, 29 (Suppl II):32, 1971.

• 8) Kojima, M.:The role of antidiuretic hormone in congestive heart failure. Jap. Circulation J., 30:525, 1966.

• 9) Tomomatsu, T., et al.:Catecholamine in congestive heart failure (Report I) . Jap. Heart J. 4113, 1963.

• 10) Ueba, Y. et al:Catecholamine in congestive heart failure (Reportl) . Jap. Heart J., 8:242, 1967.
  pubmed

• 11) 佐藤友英, 宮下英夫:ジギタリスの血中濃度, 血液と脈管, 6:816, 1975.

• 12) Farah, A. E. and Alousi, A. A.:New cardiotonic agents, a search for a digitalis substitute. Life Sci., 22:1139, 1978.
  pubmed

• 13) Benotti, J R. et al.:Hemodynamic assessment of amrinone:New inotropic agent. New Engl. J. Med., 299:1373, 1978.
  pubmed

• 14) Awan, N. A. et al.:Development of systemic vasodilator tolerance to prazosin with chronic use of the agent in ambulatory therapy of severe congestive heart failure. Am. J. Cardiol., 41:367, 1978.

• 15) Colucci, W. S. et al:Long-term therapy of heart failure with prazosin:Arandomized double-blind trial. Am. J. Cardiol, 45:337, 1980.

• 16) Joye, J. et al.:Comparative hemodynamic effects of intravenous nitroprusside and nitroglycerin in patients with cardiac failure:Comparable results in reducing elevated preload and augmenting depressed cardiac output. Clin. Res., 28:184A, 1980.

• 17) Amsterdam, E. A. et al.:Sustained salutary effects of oral cotrolled release nitroglycerin on ventricular function in congestive heart failure. Clin. Cardiol., 2:19, 1979.

• 18) Pierpont, G. L, Cohn, J. N. and Franciosa, J. A.:Combined oral hydralazine-nitrate therapy in left ventricular failure. Chest, 78:8, 1978.

• 19) Awan, N. A. et al.:Therapeutic efficacy of concomitant nitroglycerin and dobutamine infusions for improving ischemic heart dysfunction:Complimentary beneficial combined systemic venodilatation with augmented contractility in severe coronary left ventricular failure with hypotension. Clin. Res., 28:155a, 1980.

• 20) Mason, D. T. et al.:Oral captopril in severe congestive heart failure:Sustained beneficial effects on ventricular function with six months therapy shown by cardiac catheterization, nuclear scintigraphy, treadmill exercise and symptomatology. Am. J. Cardiol., 45:411, 1980

P.241 掲載の参考文献

• 1) Schreiner, G. E.:The nephrotic syndrome:In Diseases of the Kidney. ed. by Strauss, M. B. and Welt, L. G., Little Brown& Company, Boston, 197I. p. 503.

• 2) 厚生省特定疾患ネフローゼ症候群調査研究班 (班長, 上田泰):昭和49年度研究業績, 昭50年.

• 3) Meltzer, J. I., et al.:Nephrotic syndrome:vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann. Intern. Med., 91:688, 1979.
  pubmed

• 4) 石本二見男, 上田泰, 他:ネフローゼ症候群における浮腫の特性. 綜合臨牀, 23:1013, 1974.

• 5) Glassock, K. J., et al.:Glomerulonephritis:In The kidney. ed. by Brenner, B. M., et al., Saunders Co., Philadelphia, 1976. p. 954.

• 6) Garnett, E. S. and Webber, C. E.:Changes in blood volume produced by treatment in the nephrotic syndrome. Lancet, 2:798, 1967.
  pubmed

• 7) 小椋陽介, 石本二見男:浮腫;ネフローゼ症候群, 日内会誌, 67:18, 1978,

• 8) Dorhout Mees, E. J., et al.:Observations on edema formation in the nephrotic syndrome in adults with minimal lesions. Am. J. Med., 67:378, 1979.

• 9) Wesson, L. G.:Glomerular and tubular factors in the renal excretion of sodium chloride. Medicine, 36:281, 1957.
  pubmed

• 10) James, J., et al.:Effects of infusion of hyperoncotic dextran in children with the nephrotic syndrome. J. Clin. Invest., 33:1346, 1954.
  pubmed

• 11) Grausz, H., et al.:Effect of plasma albumin on sodium reabsorption in patients with nephrotic syndrome. Kidney Internat., 1:47, 1972.

• 12) Bourgoignie, J. J., et al.:The presence of a natriuretic factor in urine of patients with chronic uremia. J. Clin. Inverst., 53:1559, 1974.

• 13) Oliver, W. J., et al:Sodium excretion in the nephrotic syndrome. Am. J. Dit. Child., 113:352, 1967.

• 14) Chonko, A. M. and Bay, W. H.:The role of renin and aldosterone in the salt retention of edema. Am. J. Med., 63:831, 1977.

• 15) Daeschner, C. W.:Factors involved in the pathogenesis of renal edema:the role of aldosterone and posterior pituitary antidiuretic hormone. In Edema. ed. by Moyer, J. H. & Fuchs, M., Saunders Co., Philadelphia, 1960, p. 511.

• 16) 東条静夫:ネフローゼ症候群;新内科学大系第37巻 (B), 吉利和, 他 (編). 中山書店, 東京, 1974, p. 219.

• 17) 阿部裕, 他:浮腫, 治療, 58:231, 1976.

• 18) 日本腎臓学会:第1次栄養委員会報告, 1977.

P.249 掲載の参考文献

• 1) Starling, E. H.:On the absorption of fluids from the connective tissue spaces. J. Physiol., 19:312, 1896.

• 2) 織田敏次, 藤原研司:腹水. 肝臓病 (高橋忠雄・織田敏次編) p. 119, 医学書院, 東京, 大阪, 1973.

• 3) Conn, H. O.:The rational management of ascites. In;Progress in liver diseases. (ed. by Popper, H. & Schaffner, F.) Vol. 4:p. 269, Grune& Stratton, New York& London, 1972.

• 4) Lieberman, F. L, Denison, E. K. & Reynolds, T. B.:The relationship of plasma volume, portal hypertension, ascites and renal sodium retention in cirrhosis;The overflow theory of ascites formation. Ann. N. Y. Acad. Sci., 170:202, 1970.

• 5) Lieberman, F. L, Ito, S. & Raynolds, T. B.:Effective plasma volume in cirrhosis with ascites evidence that a decreased value does not account for renal sodium retention, a spontaneous reduction in glomerular filtration rate, and a fall in GFR during drug-induce diuresis. J. Clin. Invest,. 48:975, 1969.

• 6) Levy, M.:Sodium retention of kidney function in dogs with experimental, portal cirrhosis. Clin. Res., 23:368, 1975.

• 7) Galambos, J. T.:Evaluation and Therapy of Ascites;cirrhosis. (ed. by Lloyd, H. S.) Vol. 17, p. 335, W. B. Saunders, Philaderphia, London& Toronto, 1979.

• 8) 関顕:肝とレニン, 医学のあゆみ, 84:171, 1973.

• 9) Rosoff, L., Zia, P., Reynolds, T. & Horton, R.:Studies of renin and aldosterone in cirrhotic patients with ascites. Gastroenterology, 69:698, 1975.
  pubmed

• 10) Abrams, J. S.:Pressor response to the portal infusion of angiotensin II. Surgery, 62:103, 1967.

• 11) Epstein, M.:Deranged sodium homeostasis in cirrhosis. Gastroenterology, 76:622, 1979.
  pubmed

• 12) Wardener, de H. E.,Mills, I.. H., Clapham, W. F. & Hayter, C. J.:Studies on the effect mechanism of the sodium diuresis which follows the administration of intravenous saline in dog. Cli. Sci., 21:249, 1961.

• 13) Bruce, D. D.:The use of ultrasound in the diagnosis of gastroenterological disease. Gastroenterology, 70:602, 1976.

• 14) 木戸長一郎, 中山正:門脈圧亢進のCT. 綜合臨牀, 29:1967, 1980.

• 15) 井上恭一, 佐々木博:肝硬変. 綜合臨牀, 29:2765, 1980.

• 16) 斎藤明, 小林快三:浮腫をめぐって. 臨床医, 6:572, 1980.

• 17) 岡崎勲, 船津和夫:肝硬変症146例の予後に関する統計学的研究. 慶応医学, 50:445, 1973.

• 18) Sherlock, S., Senewirante, B., Scott, A. & Walker, J. G.:Complication of diuretic therapy in hepatic cirrhosis. Lancet, 1:1049, 1966.

• 19) Sherlock, S.:Diseases of the liver and biliary system. 5th ed., P. 122, Blackwell, 0xford, 1975.

• 20) Liddle, G. W.:Specific and non-specific inhibition of mineralcorticoid activity. Metabolism, 10:1021, 1961.

• 21) Yamada, S., Reynolds, T. B.:Amiloride, a new antikaluretic diuretic. Gastroenterology, 59:833, 1970.
  pubmed

• 22) Le Veen, H. H., Christondias, G.:Peritoneovenous shunting for ascites. Ann. Surg., 108:508, 1974.

• 23) Arroyo, V. & Rodes, J.:Treatment of ascites. Postgrad. Med. J., 51:558, 1975.
  pubmed

P.255 掲載の参考文献

• 1) Theologides, A.:Cancer cachexia. Cancer, 43:2004-2012, 1979.
  pubmed

• 2) Waterhouse, C.:How tumor affect host metabolism. Ann. NY Acad. Sci., 230:86-93, 1974.
  pubmed

• 3) Brennan, M. F.:Uncomplicated starvation versus cancer cachexia. Cancer Research, 37:2359-2364, 1977.
  pubmed

• 4) Brown, R.:Carbohydrate metabolism in patients with endometrial carcinoma. J. Obstet. Gynecol. Br. Commonw, 81:940-946, 1974.

• 5) Glicksman, A. S. and Rawson, R. W.:Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer, 9:1127-1134, 1956.
  pubmed

• 6) Kisner, D. et al:Malignant cachexia:insulin resistance and insulin receptors. Proc. Am. Assoc. Cancer Res., 19:199, 1978.

• 7) Holroyade, C. P. et al.:Altered glucose metabolism in metastatic carcinoma. Cancer Res., 35:3710-3714, 1975.

• 8) Muller, T. S. and Watkin, D. M.:Plasma unesterified fatty acid concentration in neoplastic disease. J. Lab. Clin. Med., 57:95-108, 1961.

• 9) Waterhouse, C. and Nye, W. H. R.:Metabolic effects of infused triglyceride. Metabolism, 10:403-414, 1961.

• 10) Liebelt, R. A., et al.:Lipid mobilization and food intake in experimentally obese mice bearing transplanted tumors. Proc. Soc. Exp. Biol. Med., 138:482-490, 1971.
  pubmed

• 11) Mider, G. B., et al.:Some aspects of nitrogen and energy metabolism in cancerous subjects:A review. Cancer Res. 11:821-829, 1951.
  pubmed

• 12) Stein, T. P., et al.:Tumor-caused changes in host protein synthesis under different dietary situations. Cancer Res. 36:3926-3940, 1976.

• 13) Greenstein, J. P. and Andervont, H. B.:Liver catalase activity of tumor-bearing mice and effect of spontaneous regression and of removal of certain tumors. J. Nat. Cancer Inst., 2:345-355, 1942.

• 14) Nakahara, W. and Fukuoka, F.:Toxohormone:A Characteristic Toxic Substance Produced by Cancer Tissue. Gann 40:45-71, 1949.

• 15) 藤井節郎ほか:癌悪液質, 代謝, 15:1159-1166, 1978.

• 16) Copeland, E. M., et al.:Nutrition as an adjunct to cancer treatment in the Adult. Cancer Res., 37:2451-2456, 1977.
  pubmed

• 17) Dudrick S. J.:Parenteral nutrition techniques in cancer patients. Cancer Res., 37:2407-2413, 1977.

P.261 掲載の参考文献

• 1) Mach, R. S., Fabre, I., Muller, A. F. and Neher, R.:Edema due to sodium chloride retention with hyperaldosteronuria. classification of conditions with hyperaldosteronism. Schweiz. Med. Wshr., 85:1229, 1955.

• 2) Thorn, G. W. l Cyclic edema. Am. J. Med., 23:507, 1957.

• 3) 浦壁重治, 白井大禄, 安東明夫, 上田尚彦:特発性浮腫 綜合臨牀:23:1036, 1974.

• 4) Edwards, O. M. and Bayliss, R. I. S.:Idiopathic edema of women. Aclinical and investigative study. Quart. J. Med., 45:125, 1976.

• 5) Edwards, O. M. and Bayliss, R. I. S.:Postural fluid retention in patients with idiopathic edema:Lack of relationship to the phase of the menstrual cycle. Clin. Sci. Mol. Med., 48:331, 1975.

• 6) Thorn, G. W.:Approach to the patient with idiopathic edema or swelling. J. A. M. A., 206:333, 1968.
  pubmed

• 7) Horky, K. and KUchel, O.:Compulsive salt intake and edema. Lancet, 2:261, 1967.

• 8) Streeten, D. H. P.:Idiopathic edema. pathognesis, clinical features and treatment. Met. clin. Exp., 27:353. 1978.

• 9) Delkers, W., Rawer, C., Widerholt, M., et al.:Anamnesen und Endokrinologische Befunde bei Frauen mit Idiopathischem Oedem. Klin. Wshr., 55:495, 1977.

• 10) Gill, J. R., Waldmann, T. A. and Bartter, F. C.:Idiopathic edema I. Am. J. Med. 52:444, 1972.
  pubmed

• 11) Gill, J. R., Cox. J., Delea, C. S. and Bartter, F. C.:Idiopathic edema. II. Am. J. Med., 52:452, 1972.
  pubmed

• 12) Sims, E. H., Mackay, B. R. and Shirai, T.:The relation of capillary angiopathy and diabetes mellitus to idiopathic edema. Ann. Int. Med., 63:972, 1965.

• 13) Coleman, M., Horwith, M. and Brown, J. L.:Idiopathic edema. Am. J. Med., 49:106. 1970.

• 14) Shaw, R. W., Kryston, L. J., Fleishmajer, R., et al.:The rationale for treatment of idiopathic edema. Am. J. Cardiol., 21:115:1968.

• 15) KUchel, O., Horsky, K. Gregororova, I., et al.:Inappropriate response to upright posture. A precipitating factor in the pathogenesis of idiopathic edema Ann. Int. Med. 73, 245, 1970.

• 16) Fisher, D. A. and Morris, M. D.:Idiopathic edema and hyperaldosteronuria. pediat 35. 413, 1965.

• 17) Streeten, D. H. P., Louis, L. H. and Conn, J. W.:Secondary aldosteronism in "idiopathic edema" . Trans. Assoc. Am. Physicians, 73:227. 1960.

• 18) Streeten, D. H. P. and Syracuse, N. Y.:Studies on the pathogenesis of idiopathic edema. Clin. Res., 13:235, 1865.

• 19) Streeten, D. H. P. and Speller, P. J.:The role of aldosterone and vasopressin in the postural changes in renal excretion in normal subjects and patients with idiopathic edema. Metab., 15:53, 1966.

• 20) Mach. R. S., Fabre. J, Muller, A. F., et al:Edema due to sodium chloride retention with hyperaldosteronuria. Med:Wshr., 85:1229, 1955.

• 21) Conn, J. W., Rovner, D. R. and Cohen, E. L. Normal:and altered function of the renin-angiotensin-aldosterone system in man. Ann. Int. Med., 63:266, 1965.
  pubmed

• 22) Werning, C., Baumann, K., Gysling, E., et al.:Renin und Aldosterone bei idiopathischen Oedemen. Klin. Wshr., 47:1256, 1969.

• 23) Katz, F. H.:Diurnal variation of plasma renin activity. aldosterone and cortisol in idiopathic edema. J. Clin. Endcri. Metab., 45:419, 1977.

• 24) Norbiato, G., Bevilacqua, M., Raggi, U., et al.:Effect of metoclopro mide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema possible therapeutic approach with levodopa and carbidopa. J. Clin. Endocri. Met., 48:37, 1979.

• 25) Kuchel, O., Cuche, J. L, Buu, N. T., et al.:Catecholamine excretion in idiopathic edema decreased dopamine excretion, a pathogenic factor. J. Clin. Endocri. Met, 44:639, 1977.

• 26) Goldberg, L L:Cardiovascular and renal action of dopamine:Potential clinical applications. Pharm. Rev., 24:1, 1972.

• 27) Kuchel, O., Hamet, P., Cuche, J. L., et al.:Urinary and plasma cyclic AMP in patients with idiopathic edema. J. Clin. Endcrin. Met., 41:282. 1975.

• 28) Streeten, D. H. P. and Speller, D. J.:The role of aldosterone and vasopressin in the postural changes in renal excretion in normal subjects and patients with idiopathic edema. Metab. Clin. Exp., 15:53, 1966.

• 29) Debereceni, L and Csete, B.:Idiopathic edema due to an increased sensitivity of renal tubular cells to vasopressin. Endokrinologie, 56:11, 1970.

• 30) Gill, J. R., Mason, D. T. and Bartter, F. C.:Idiopathic edema resulting from occult cardiomyopathy. Am. J. Med., 38:475, 1965.
  pubmed

• 31) Streeten, D. H. P., Eich, R. H., Smulyan, H., et al.:Hemodynamic and metabolic changes in idiopathic edema. J. Lab. Clin. Med., 70:1022, 1967.

• 32) Obeid, A. I., Streeten, D. H. P., Eich, R. H., et al:Cardiac function in idiopathic edema. Arch. Int. Med., 134:253, 1974.

• 33) Clarkson, B.:Cyclice edema and shock due to increased capillary permeability. Am. J. Med., 29:193, 1960.

• 34) 折田義正, 藤原芳広, 吉川隆一, 繁田幸男, 高光義博, 佐々木栄喜, メサンギウム増殖性糸球体腎炎患者のNa排泄動態-体位変換時の, exaggerated antinatriuresis. 日本医師会誌, 85:245, 1981.

P.269 掲載の参考文献

• 1) Oliver, J., MacDowell, M., and Tracy, A.:The pathogenesis of acute renal failure associated with traumatic and toxic injury:Renal Invest., 30:1307, 1951.
  pubmed

• 2) Bank, N., Mutz, B. F., and Aynedjian, H. S.:The role of "leakage" of tubular fluid in anuria due to mercury poisoning. J. Clin. Invest., 46:695, 1967.
  pubmed

• 3) DiBona, G. F., and Sawin, L L:The renin-angiotensin system in acute renal failure in the rat. Lab. Invest., 25:528, 1971.
  pubmed

• 4) Ruiz-Guinazu, A., Coelho, J. B., and Paz, R. A.:Methemoglobin-induced acute renal failure in the rat. In vivo observation, histology and micropuncture measurements of intratubular and postglomerular vascular pressures. Nephron, 4:257, 1967.
  pubmed

• 5) Oken, D. E., Arce, M. L., and Wilson, D. R.:Glycerol-induced hemoglobinuric acute renal failur ein the rat:I. Micropuncture study of the development of oliguria. J. Clin. Invest., 45:724, 1966.

• 6) Tanner, G. A., and Sophasan, S.:Kidney pressure after temporary renal artery occlusion. Am. J. Physiol. 230:1173, 1976.
  pubmed

• 7) Flamenbaum, W.:Pathophysiology of acute renal failure. Arch. Intern. Med., 131:911, 1973.
  pubmed

• 8) Flamenbaum, W., Huddleston, M. H., McNeil, J. S., et al.:Uranyl nitrate-induced acute renal failure in the rat:Micropuncture and renal hemodynamic studies. Kidney Int., 6:408, 1974.

• 9) Hollenberg, N. K., Adams, D. F., Oken, D. E., et al.:Acute renal failure due to nephrotoxins:Renal hemodynamic and angiographic studies in man. N. Engl. J. Med. 282:1329, 1970.

• 10) Chedru, M. F., Baethke, R., and Oken, D. E.:Renal cortical blood flow and glomerular filtration in myohemoglobinuric acute renal failure. Kidney Int., 1:232, 1972.
  pubmed

• 11) Ayer, G., et al.:Intrarenal hemodynamics in glycerol. induced myohemoglobinuric acute renal failure in the rat. Circ. Res., 29:128, 1971.
  pubmed

• 12) Cox, J. W., et al.:Studies on the mechanism of oliguria in a model of unilateral acute renal failure. J. Clin. Invest., 53:1546, 1974.

• 13) Schrier, R. W., et al.:Nephropathy associated with heat stress and exercise. Ann. Intern. Med., 67:356, 1967.
  pubmed

• 14) Brown, J. J., et al.:Renin and acute renal failure:Studies in man. Br. Med. J. 1:253, 1970.
  pubmed

• 15) Kokot, F., and Kuska, J.:Plasma renin activity in acute renal insufficiency. Nephron, 6:115, 1969.
  pubmed

• 16) Vertel, R. M., and Knochel, J. P.:Non-oliguric acute renal failure. J. A. M. A., 200:598, 1967.

• 17) Flores, J., et al.:The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J. Clin. Invest., 51:118, 1972.
  pubmed

• 18) Frega, N., DiBona, D. R., and Leaf, A.:Ischemic renal injufy. Kidney Int., 10:517, 1976.

• 19) Cronin, R. E., et al.:Pathogenic mechanisms in early norepinephrine-induced acute renal failure:Functional and histological correlates of protection. Kidney Int., 14:115, 1978.
  pubmed

• 20) Bricker, N. S., et al.:A humoral inhibitor of sodium transport in uremic serum. Arch. Intern. Med., 126:860, 1970.
  pubmed

• 21) Bourgoignie, J. J., et al.:A natriuretic factor in the serum of patients with chronic uremia. J. Clin. Invest., 51:1514, 1972.
  pubmed

• 22) Bourgoignie, J. Jl, et al:The presence of natriuretic factor in urine of patients with chronic uremia. The absence of the factor in nephrotic uremic patients. J. Clin. Invest., 53:1559, 1974.

• 23) Guyton, A. C., et al.:Arterial pressor regulation. Overriding dominance of the kidneys in long-term regulation and hypertension. Am. J. Med., 52:584, 1972.

• 24) Guyton, A. C., et al.:Quantitative analysis of the pathophysiology of hypertension. Circ. Res. 24, 25:I-1, 1969.

• 25) Davies, D. L.:Abnormal relation between exchangeable sodinm and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure. Lancet, 1:683, 1973.

• 26) Weidman, P., Maxwell, M. H., and Lupu, A. N.:Plasma aldosterone in terminal renal failure. Ann. Intern. Med., 78:13, 1973.

• 27) Blumberg, A., et al.:Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction. Lancet, II:69, 1967.

• 28) Maeda, K., Kawaguchi, S., Shimizu, K., Manji, T., Kobayashi, K., Ohta, K., Saito, A., Amano, I., Yoshiyama, N., Nakagawa, S., and Koshikawa, S.:Ten Litre Dialysate Supply System with Adsorbents. Proceedings of the European Dialysis and Transplant Association, 11:180, 1974.

• 29) 前田憲志, 小林千太郎:血液透析, 腎と透析, 8-1:97, 1980.

• 30) Maeda, K., Kawaguchi, S., Kobayashi S. Niwa, T., Kobayashi, K., Saito, A., Iyoda, S., and Ohta, K.:Cell-Wash Dialysis (CWD) . Trans. Am. Soc. Artif. Int. Organs, 26:213, 1980.

P.280 掲載の参考文献

• 1) Shires, T. M. D., et al:Fluid therapy in hemorrhagic shock. Arch. Surg., 88:688, 1964.

• 2) Baxter, C. R., M. D.,:Fluid volnme and electrolyte changes of the early postburn period. Clin. in Plast. Snrg., 1:693, 1974.

• 3) Arturson, G.:Quantitative changes in capillary filtration, diffusion and permiability in experimental burns. Research in Burns. Ed. by Wallace, A. B. & Wilkinson, A. W., Livingstone Ltd, Edinburg. 1966.

• 4) Day, C., et al.:Tissue sodium concentration after thermal burn. J. Trauma, 12:1063, 1973.

• 5) 八木義弘, 笹生幹夫:熱傷ショックと治療, 外科Mook, 9:145, 1979.

• 6) Baxter, C. R., Comtemporary Burn Management. Ed. by Polk, H. C. & Stone, H. H., 1971, Little Brown, Boston.

• 7) 杉本侃, 他:ショックの病態, 外科治療, 36:160, 1977.

• 8) 八木義弘:熱傷の治療, 外科卒後教育セミナー (6), 日本外科学会卒後教育委員会編, p. 1-44, 1977, 中外医学社, 東京.

• 9) Monafo, W. W.:The treatment of burn shock by the intravenous and oral adminstration of hypertonic lactated saline solution. J. Trauma, 101575, 1970.

• 10) 島崎修次, 他:HLS療法の作用機序に関する基礎的研究, 日災害医誌,23: 325, 1974.

• 11) 八木義弘:熱傷治療の動向, 日本医事新報, 2953:15, 1980.

P.291 掲載の参考文献

• 1) 高折益彦, 田中彰:体液管理, 綜合臨牀 27:891-896, 1978.

• 2) Weil, M. H. & Henning, R. J.:New concepts in the diagnosis and fluid treatment of circulatory shock Anesth. Analg., 58:124-132, 1978.

• 3) Chien, S,:Quantitative evaluation of the circulatory adjustment of splenectomized dogs to hemorrhage Am. J. Physiol, 193:605-614, 1958.
  pubmed

• 4) Skillman, J. J., Eltringham, W. F., Goldensen, R. H. & Moore, F. D.:Transcapillary refilling after hemorrhage in the splenectomized dog. J. surg. Res., 8:57-67, 1968.

• 5) Pirkle, J. C., Jr. & Gamn, D. S.:Restitution of blood volume after hemorrhage:role of the adrenal cortex. Am. J. Physiol, 230:1683-1687, 1976.

• 7) Skillman, J. J., Awwad, H. K. & Moore, F. D.:Plasma protein kinetics of the early transcapillary refill after hemorrhage. Surg. Gyn. & Obst.:125:983-996, 1967.
  pubmed

• 8) Malt, R. A., Wang, C., Yamazaki, Z. & Miyakuni, T. Stimulation of albumin synthesis by hemorrhage Surgery, 61:422-426. 1967.

• 9) Shires, T., Williams, J. & Brown, F.:Distributional changes in extracellular fluid during acute hemorrhagic shock. Surg., Forum 11:115-120, 1960.

• 10) Holcraft, J. W. & Trunkey. D. D.:Extravascular lung water following hemorrhagic shock in the baboon:Comparison between resuscitation with Ringer's lactate and plasmanate Ann. Surg, 180:408-417, 1974.

• 11) Holcroft, J. W., Trunkey, D. D. & Lim, R. C.:Further analysis of lung water in baboons resuscitated from hemorrhagic shock J. surg., Res 20:291-297, 1976.
  pubmed

• 12) 高折益彦:ショック時の体液バランス, 臨床科学, 16:663-668, 1980.

• 13) Hossman, K. A. & Takagi, S.:Osmolality of brain in cerebral ischemia Exper. Neurol., & 51:124-131, 1976.

• 14) Allen, H. N., Danzig, R. & Swan, H. J. C.:Incidence and significance of relative hypovolemia as a cause of shock associated with acute myocardial infarction Circulation, 36:II-50, 1967.

• 15) Da Luz, P. L., Shubin, S. H., Weil, M. H. & Stein, L Plasma.:volume in shock associated with myocardial infarction Am. J. Cardiol. 29:259, 1972.

• 16) Loeb, H. J., Pietras, R. J., Tobin, J. R. & Gunner, R. M.:Hypovolemia in shock due to acute myocardial infarction Circulation, 40:653-659, 1969.

• 17) DaLuz, P. L., Weil, M. H., Liu, V. Y. & Shubin, H.:Plasma volume prior to and following volume loading during shock complicating acute myocardial infarction Circulation, 49:98-105, 1974.

• 18) Flear, C. T. G.:Disturbance of volume and composition of body fluids in congestive heart failure. Electrolytes and Cardiovascular Diseases 2:357-366, Karger, S., Basel/New York, 1966.

• 19) Squires, R. D., Crosley A. P., & Elkinton, J. R.:The distribution of body fluids in congestive heart failure Circulation, 4:868-880, 1951.
  pubmed

• 20) Richards. D. W.:The circulation in traumatic shock in man Harvey Lect., 39:217-253, 1943.

• 21) Ebert. R. V. & Stead, E. A.:Jr. Circulatory failure in acute infections. J. clin. Invest. 20:671-679, 1941.

• 22) MacLean, L. D., Mulligan, W. G., MacLean, A. P. H. & Duff, J. H.:Patterns of septic shock in man-a detailed study of 56 patients Ann. Surg., 166:543-562, 1967.

• 23) Hardaway, R. M.:The role of intravascular clotting in the etiology of shock Ann. Surg, 155:325-338, 1962.
  pubmed

• 24) Franke, F. E.:Action of toxic doses of the polysaccharide from Seratia Marcescens (Bacillus Prodigious) on the dog and guinea pig J. Nat. Can. Inst., 5:185-193, 1944-1945.

• 25) Favoritte, G. O. & Morgan, H. R.:Effects produced by intravenous injections in man toxic antigenic material derived from Eberthella typhosa.:Clinical, hemotological, chemical and serological studies J. clin. Invest., 21:589-599, 1942.

• 26) Broido, P. W. & Butcher, H. R.:Sodium space determination in shock J. surg, Res., 8:482-490, 1968.

• 27) 高折益彦:中心静脈圧 (CVP) 現代臨床機能検査 (日本臨床37巻夏期増刊号), 日本臨床社, 大阪, 1979. p:580-582.

• 28) Sykes, M. K.:Venous pressure as a clinical indication of adequate of transfusion Ann. Royal Coll Surg. 33:185-197, 1963.

• 29) 広江道昭:心内圧および肺動脈圧, 現代臨床機能検査 (日本臨床37巻夏期増刊号) 日本臨床社, 大阪1979. p:583-587.

• 30) Fieber, W. W. Jones, J. R., & Nebraska, O.:Operative fluid therapy II. Anesth. Analg, 46:401-404, 1967.

• 31) Robin, E. D., Carey, L. C., Grenvik, A. Glauser, F. & Caudio, R.:Capillary leak syndrome with pulmonary edema Arch. intern. Med., 130:66-71, 1972.

• 32) Vreim, C. E. & Staub, N. C.:Protein composition of lung fluids in acute alloxan edema in dogs Am. J. Physiol. 230:376-379, 1976.
  pubmed

• 33) Figueras, J. & Weil, M. H.:Blood volume prior to and following treatment of acute cardiogenic pulmonary edema Circulation 57:349-355, 1978.
  pubmed

• 34) 田中彰, 高折益彦, 中条信義:水分バランスの指標としての赤血球比重, ICUとCCU 3:385-389, 1979.

• 35) 田中彰, 高折益彦:赤血球比重に関する研究 ICUとCCU 4:1151-1156, 1980.

• 36) Zollman, W., Culpepper, R. O., Turner, M. D., Hardy, J. A. & Hardy, J. D.:Hemorrhagic shock in dogs:Comparison of treatment with shed blood plus Ringer's lactate:Intravascular pressures, cardiac output, oxygen consumption, arteriovenous oxygen differences, extracellular fluid Po2, electrolyte changes, and survical rates Am. J. Surg., 131:298-305, 1978.

• 37) 中条信義, 小川秀樹, 高折益彦:出血性ショック治療と臓器血夜量, 臓器血流量変化, 麻酔27:1047-1053, 1978.

• 38) 高折益彦:脱水治療の輸液と休液分画変化-輸液剤の影響, 麻酔 (昭和56年10月掲載予定).

• 39) Ratshin, R. A., Rackley, C. E. & Russell, R. O.:Jr. Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction Circulation, 45:127-139, 1972.
  pubmed

• 40) Green, H . L., Kelly, t D. T., Taylor, D. R. & Pitt, B. Hemodynamic effect of volume expansion and prognostic implications in acute myoccardial infarction Circulation 49:106-114, 1974.

• 41) Stein, L, Beraud, J-J., Morissette, M. Da Luz. P., Weil,M.H.& Shubin, H.:Pulmonary edema during volume infusion Circulation 52:483-489, 1975.

• 42) Nixon. P. G. F., Ikram, H. & Morton, S. Cardiogenic shock treated with infusion of dextran solution Am. Heart, J. 73:843-845, 1967.

• 43) Schmidt-Schonbein, Rieger, H. & Messmer, K. The Third International Symposium on "Hemodilution and Flow Improvement" Dec. 7-10, Pontresina, Switzerland, 1980.

• 44) Barankay, T. & Nagy, S.:Effects of haemodilution in experimental cardiogenic shock. Acta physiol Acad. Sci. Hung., 49:125-133, 1977.
  pubmed

P.314 掲載の参考文献

• 1) Igo, R. P., Hickman, R. O.:Fluid Therapy in "Brememann's Practice of Pediatrics, I (1), chapter 16, Hoeber Medical Division, N. Y., London, 1969.

• 2) Finberg, L.:Pediat., 45, 1029, 1970.

• 3) Kaplan, S. A.:Fluid Therapy in Pediatrics, in "Current Pediatric Therapy" edt., by Gellis, S. S., Kagan, B. M., Saunders, Co, Ltd., (4Edt), 1970.

• 4) 美濃真:小児輸液の実際, 永井書店, 1972.

• 5) Finberg, L l New Engl. J. Med., 289, 196, 1973.

• 6) Weil, W. B.:J. Pediat., 83, 359, 1973.
  pubmed

• 7) 美濃真:小児内科, 12, 2I. 1981.

• 8) Winters, R. W.:The Body Fluids in Pediatrics, Little Brown Co. Ltd., 1973.

• 9) Weil, W. B., Bailie, M. D.:Fluid and Electrolyte Metabolism in Infants and Children, Grune& Stration, Co., 1977.

P.325 掲載の参考文献

• 1) 飯田喜俊, 村上徳代:意識障害患者の輸液療法と管理の実際, 臨床看護, 2 :79, 1976.

• 2) Weitzman, R., and Kleeman, C. R.:Water metabolism and the neurohypophyseal hormones. Clinical Disorders of Fluid and Electrolyte Metabolism. ed. Maxwell, M., and Kleeman, C. R., 3rd ed. McGraw-Hill Book Co., 531, 1980.

• 3) Arieff. A. I., and Schmidt, R. W. l Fluid and electrolyte disorders and the central nervous system. Clinical Disorders of Fluid and Electrolyte Metabolism. ed. Maxwell, M., and Kleeman, C. R., 3rd ed., McGraw-Hill Book Co., 1409, 1980.

• 4) Williams, R. H.:Textbook of Endocrinology. 5th ed., W. B. Saunders Co., 270, 1974.

• 5) Thornborough, J. R., Passo, S. S., and Rothballer, H. B.:Receptors in cerebral circulation affecting sodium excretion in the cat. Am. J. Physiol., 225:138, 1973.

• 6) Park, R., Guisado, R., and Arieff, A. I.:Nutrient deficiencies in man:Water, in CRC Handbook of Nutrition and Food, CRC Press in press.

• 7) Gauer, D. H., and Henry, J. P:Circulatory basis of fluid volume control. Physiol. Rev., 43:423, 1963.

• 8) Henry, J. P., Gupta, P. D. Meehan, J. P., Sinclair, R. and Share, L.:The role of afferents from the low pressure system in the release of anti-diuretic hormone during non-hypotensive hemorrhage. Canad. J. Physiol. Pharmacol., 46:287, 1968.

• 9) Zuker, I. H. and Kaley, G.:Natriuresis induced by intracarotid infusion of hypertonic sodium chloride. Am. J. Physiol., 230:427, 1976.

• 10) Fitzsimmons, J. T.:Thirst. Physiol Rev., 52:468, 1972.

• 11) Fitzsimmons, J. T. and Simmons, B. J.:The effect on drinking in the rat of intravenous infusion of angiotensin given alone or in combination. J. Physiol. 203:45, 1969.
  pubmed

• 12) Simpson, J. B., Epstein, A. N. and Camardo, J. S.:Dose-response analysis of angiotensin. induced drinking at subformical organ and third ventricle. Physiologist, 18:391, 1975.

• 13) Hoffman, W. E. and Phillips, M. I.:Blockage of blood pressure and drinking responses to angiotensin by anterior third ventricle obstruction. Fed. Proc., 34:374, 1975.

• 14) 飯田喜俊:口渇とレニンアンジオテンシン系, 医学のあゆみ, 103:10, 1977.

• 15) Simpson, . I. B., Epstein, A. N. and Camardo, J. S.:Ablation or competitive blockade of some subfornical organ prevents thirst of intravenous angiotensin. Fed. Proc. . 24:374, 1975.

• 16) Fitzsimmons, J. T. and Setler, P. E.:The relative importance of central nervous catecholaminergic and cholinergic mechanisms in drinking in response to angiotensin and other thirst stimuli. J. Physiol., 250:613, 1975.

• 17) Ramwell, P. W. and Shaw, J. E.:Biological significance of the prostaglandins. Recent Prog. Horm. Res., 26:139, 1970.
  pubmed

• 18) Berl, T., Anderson, R. J., Aisenbrey, G., Linas, S., and Schrier, R.:On the mechanism of polyuria in potassium depletion. The role of polydipsia. Clin. Res., 25:136A, 1977.

• 19) Leksell, L:Influence of prostaglandin E1 on cerebral mechanisms involved in the control of fluid balance. Acta Physiol. Scand., 98:85, 1976.
  pubmed

• 20) Smith, R. J., Block, M. R., Arieff, A. I., Blumenkrantz, M. J., and Coburn, J. W.:Hypernatremic hyperosmolar coma chronic peritoneal dialysis. Proceedings of the clinical transplant forum, 4:96, 1974.

• 21) Bleumle, L. W.:Current status of chronic hemodialsis, Am. J. Med., 44:749, 1968.

• 22) Banister, A., Siddiqi, S. A.M., Hatcher. G. W.:Treatment of hypernatremic dehydration in infancy. Arch. Dis. 1975.

• 23) Bruck, E., Abal, G., and Aceto, T.:Pathogenesis and pathophysiology of hypertonic dehydration with diarrhea. 122, 1968.
  pubmed

• 24) Brenner, B. M., and Stein, J. H.:Sodium and water homeostasis Churchill Livingstone, 212, 1978.

• 25) Finberg, L. and Harrison, H. E.:Hypernatremia in infants. An evaluation of the clinical and biochemical findings accompanying this state. Pediatrics, 16:1, 1955.
  pubmed

• 26) Habel, A. H. and Simpson, H.:Osmolar relationship between CSF and serum in hyperosmolar hypernatremic dehydration. Arch. Dis. Child., 50:331, 1975.

• 27) Finberg, L.:Hypernatremic (hypertonic) dehydration in infants. N. Engl. J. Med., 289:196, 1973.
  pubmed

• 28) Sparacio, R. R., Anziska, B. and Schutta. H. S.:Hypernatremia and chorea:A report of two cases. Neurology, 26:46, 1976.
  pubmed

• 29) Sotos, J. F., Doge, P. R., Meara, P. and Talbot, N.B.:Studies in experimental hypertonicity. I. Pathogenesis of the clinical syndrome, biochemical abnormalities and cause of death. Pediatrics, 26:925, 1960.

• 30) Finberg, L., Luttrell, C. and Redd, H.:Pathogenesis of lesions in the nervous system in hypernatremic states:experimental studies of gross anatomic changes and alterations of chemical composition of the tissues. Pediatrics, 23:46, 1959.
  pubmed

• 31) Arieff, A. I. and Guisada, R.:Effects on the central nevous system of hypernatremic and hyponatremic states. Kidney Intern., 10:104, 1976.

• 32) Arieff, A. I., Guisado, R. and Lazarowitz, V. C.:The pathophysiology of hyperosmolar states. In Distruvances in Body Fluid Osmolality. ed. Andreoli, T. E., Grantham, J. J. and Rector, F. C., The American Physiological Society, Bethesda, 227, 1977.

• 33) Thurston, J. H., Hauhart, R. E., Jones, E. M. and Ater, J. L.:Effects of salt and water loading on carbohydrate and energy metabolism and levels of selected amino acids in the brains of young mice. J. Neurochem., 24:953, 1975.
  pubmed

• 34) Detroyer, A. and Demanet, J. C.:Clinical, biological and pathogenic features of the syndrome of inappropriate secretion of antidiuretic hormone. Quart. J. Med., 45:521, 1976.

• 35) Demanet, J. C., Bonnyns, M., Bleiberg, H. and Stevens-Rocmans, C.:Coma due to water intoxication in beer drinkers. Lancet, 2:1115, 1971.

• 36) Wildenthal, K., Mierzwiak, D. S., Meyers, R. W. and Mitchell, J. H.:Effects of acute lactic acidosis on left ventricular performance. Am. J. Physiol., 214:1352, 1968.

P.336 掲載の参考文献

• 1) Mason, E.:"Fluid, Electrolyte& Nutrient therapy in Surgery" . Lee & Febiger, Phil, 1974.

• 2) 藤田達士:術中輸液, 臨床と研究, 56, 3320, 1979.
  Medical*Online

• 3) Swartz, C.:Hypernatremia, pp. 35-42. in "Critical Care" (Editors, Oaks, Bharadwaja, & Major) Grunne& Stratton, N. Y., 1978.

• 4) 古屋清一:外科と水・電解質, pp. 25-37. 外科Mook No. 3, 金原出版, 1978.

• 5) Levin, R. L.:Hyperosmolar Hyperglycemic Coma, pp. 45-52, in "Critical Care" (Editors, Oaks Bharaduaja& Major) Grunne& Stratton N. Y., 1978.

• 6) Hopkinson, B. R. et al:Interstitial fluid pressure changes during hemorrhage and blood replacement with and without hypotension. Surgery, 64, 68, 1968.
  pubmed

• 7) Broido, P. W. et al:Abioassay of treatment of hemorrhagic shock. II, The expansion of extracellular ions during hemorrhagic hypotension and possible relation to alterations in extravascular-extracellular tissue. Arch. Surg., 93, 556, 1966.

• 8) De Palma, R. G. et al:Fluid therapy in experimental hemorrhagic shock:ultrastructure effects in liver and muscle. Ann. Surg., 175:539, 1972.
  pubmed

• 9) Fountain, S. S. et al:The dynamics of Posttraumatic intestinal fluid sequestration, S. G. O., 123, 1237, 1966.

• 10) Flear C. T. G. et al:Hyponatremia and Sick Cells, Brit. J. Anaesth, 45, 976, 1973.

• 11) 後藤文夫ほか:未発表データ.

• 12) Doty D. B. et al:Sequential changes in blood volume following injury and transfusion, S. G. O., 130. 801, 1970.

• 13) Getzen L. C. et al:The effect of fluid infusions upon serum protein concentrations during hemorrhagic shock. S. G. O., 146, 745, 1978.

• 14) Hauser, C. J. et al:Oxygen transport responses to colloids and crystalloids in critically in surgical patients. S. G. O., 150, 811, 1980.

• 15) Moss, G. S. et al:Changes in lung ultrastructure following heterologous and homologous serum albumin infusion in the treatment of hemorrhagic shock. Ann. Surg., 189, 236, 1979.
  pubmed

• 16) 戸沢隆司:術後hypoxiaと血清浸透圧, 麻酔, 27, 1477, 1978.

• 17) 藤田達士:術中輸液・臨床と研究, 56, 3320, 1979.
  Medical*Online

• 18) Schrier, R. W.:Disorders of water metabolism. pp. 1-44. "Renal and Electrolytes disorders" (Editors) Schrier R. W. et al. Little& Brown Co. Boston, 1976.

• 19) Powers S. R. Jr.:Shock and metabolism, S. G. O., 140, 211, 1975.

• 20) Miletich, D. J. et al:Response to fasting and lipid infusion of epinephrine induced arrythmias during halothane anesthesia. Anes. thesiology, 48, 245, 1978.

• 21) 佐藤登志郎ほか:体液制御モデルとコンピューター介助による輸液指針, 医学のあゆみ, 110, 828, 1979.

P.344 掲載の参考文献

• 1) Gamble, J. L.:Chemical Anatomy, Physiology and Pathophysiology of Extracellular Fluid, 6th Ed. Cambridge Mass. Harvard University Press, 1954.

• 2) Bland, J. H.:Clinical Metabolism of Body Fluid and Electrolytes, Philadelphia. W. B. Saunders Co. 1963.

• 3) 加藤暎一, 山内真:体液バランスの基礎と臨床, 東京, 文光堂, 1965.

• 4) 加藤暎一:これからの輸液理論のあり方, 治療:62:1559, 1980.

• 5) Giebisch, G.:酸・塩基平衡の異常 (Bricker, N. S. 編The Sea within Us) p.35, 1975, Searle & Co (日本語訳, マルピーサール社提供)

P.352 掲載の参考文献

• 1) Harrison's "Principles of Internal Medicine" 9th ed. p. 56 McGraw. Hill Book Co. New York, 1979.

• 2) 杉本侃ほか:高温環境下の障害. 総合臨牀, 29:555, 1980.

• 3) 日野和徳:紫外線および赤外線による障害. 新内科学大系, 59B, p. 192, 中山書店, 東京, 1976.

• 4) 三浦豊彦:作業環境条件の整備, C. 温熱条件. 新労働衛生ハンドブック, p. 198, 労働科学研究所, 東京, 1975.

• 5) 島崎修次:日射病, 熱射病. 本間日臣他編集, 救急プライマリケアハンドブック, p. 636, 克誠堂出版, 東京, 1980.

• 6) 武下浩, 蔵本照雄:高温・低温による意識障害. 日本医事新報, 2765:34, 1977.

• 7) Shibolet, S. et al.:Heat stroke:A review. Aviation, space, Environ. Med., 47:280, 1976.

• 8) Shibolet, S. et al.:Heatstroke:Its clinical picture and mechanism in 36 cases. Quart. J. Med., 36:525, 1967.
  pubmed

• 9) Knochel, J. P. et al.:The renal, cardiovascular, hematologic and serum electrolyte abnormalities of heat stroke. Am. J. Med., 30:299, 1961.
  pubmed

• 10) 高須照夫:低ナトリウム血症. 新内科学大系, 48B, p 87, 中山書店, 東京, 1979.

• 11) Kew, M. C. et al:The heart in heatstroke. Am. Heart J., 77:324, 1969.
  pubmed

• 12) Ruppert, R. D. et al:The mechanisms of metabolic acidosis in heatstroke. Clin. Res., 12:316, 1964.

• 13) Schrier, R. W. et al.:Renal metabolic, and circulatory responses to heat and exercise. Ann. Intern. Med., 73:213, 1970.
  pubmed

• 14) O'Donnell, T. F.:Acute heat stroke. JAMA, 234:824, 1975.
  pubmed

• 15) Stefanini, M., and Spicer, D. D.:Hemostatic breakdown, fibrinolysis, and acquired hemolytic anemia in a patient with fatal heat stroke:Pathogenetic mechanisms. Am. J. Clin. Pathol., 55:180, 1971.

• 16) Kew, M. C. et al.:The effects of heat stroke on the function and structure of the kidney. Quart. J. Med., 36:277, 1967.

• 17) Vertel, R. M. and Knockel, J. P.:Acute renal failure due to heat injury:An analysis of ten cases associated with a high incidence of myoglobinuria. Am. J. Med., 43:435, 1967.

• 18) Kew, M. C. et al.:Liver darnage in heatstroke. Am. J. Med., 49:192, 1970.

• 19) Sohar, E. et al.:Heatstroke caused by dehydration and physical effort. Arch. Intern. Med., 122:159, 1968.
  pubmed

• 20) Clowes, G. H. A. and O'Donnell, T. F. l Current concepts, Heat stroke. N. Eng. J. Med., 291:564, 1974.

• 21) Eichler, A. C. et al.:Heat stroke. Am. J. Surg., 118:855, 1969.
  pubmed

• 22) Weber, M. B., and Blakely, J. A. The hemorrhagic diathesis of heatstroke. A consumption coagulopathy successfully treated with heparin. Lancet, 1:1190, 1969.
  pubmed

P.364 掲載の参考文献

• 1) Bradley, R. F.:Diabetic ketoacidosis and coma. In Joslin's Diabetes Mellitus. p. 361, Eds. Marble, A., et al., Lea and Febiger, Phila-delphia, 11th ed., 1971.

• 2) 後藤由夫:糖尿病昏睡, 臨牀と研究, 49:337, 1972.
  Medical*Online

• 3) 久野昭太郎:ケトン性糖尿病性昏睡, 糖尿病学の進歩, 第9集, p 185, 1975.

• 4) Felig, P., et al.:Plasma amino acid levels in diabetic ketoacidosis. Diabetes, 19:727, 1970.

• 5) 木村栄一ほか:糖尿病のアミノ酸代謝, 糖尿病, 12:232, 1969.

• 6) McGarry, J. D., et al:The role of carnitine in hepatic ketogenesis. Proc. Natl. Acad. Sci. U. S. A., 72:4385, 1975.
  pubmed

• 7) Huth, W., et al.:Regulation of ketogenesis at the site of acetyl CoA acetyltransferase. In Biochemical and clinical aspects of ketone body metabolism. International Symposion Reinhausen. p. 11, Eds. Soling, H. D. and Senfert, C. D., 1979.

• 8) Garber, A. J., et al:Hepatic ketogenesis and gluconeogenesis in human. J. Clin. Invest., 54:981, 1974.

• 9) Koehler, A. E., et al:Acetone and acetoacetic acid metabolism in man. J. Biol. Chem., 140:811, 1941.

• 10) Sherwin, R. S. et al.:Effect of diabetes mellitus and insulin on the turnover and metabolic response to ketones in man. Diabetes, 25:776, 1976.
  pubmed

• 11) Sapir, D. G., et al.:Renal conversion of ketone bodies during starvation. Metabolism, 24:23, 1975.

• 12) Randle, P. J., et al.:Control of the tricarbocyclic and its interactions with glycolysis during acetate utilization in rat heart. Biochem. J., 117:677, 1970.

• 13) 小出 輝:ナトリウム, カリウム, 塩素-その数値をどう読むか-血液, 尿化学検査, p. 231, 日本臨床, 秋季増刊, 1976.

• 14) Kety, S. S., et al.:The blood flow and oxygen consumption of the human brain in diabetic acidosis and coma. J. Clin. Invest., 27:500, 1948.

• 15) Ditzel, J.:The oxgen transport system of red blood cells during diabetic ketoacidosis and recovery. Diabetologia, 11:255, 1975.

• 16) Bridges, J. M., et al.:An effect of D-glucose on platelet stickness. Lancet, I:75, 1965.

• 17) Sagel, J., et al.:Increased platlet aggregation in early diabetes mellitus. Ann. Int. Med., 82:733, 1975.

• 18) Timperley, W. R., et al:Cerebral intravascular coagulopathy in diabetic ketoacidosis. Lancet, II:952, 1974.

• 19) Christensen, N. J., et al.:The relationships between endogenous serum insulin concentration and glucose uptake in the forearm muscles of non diabetes. J. Clin. Invest., 47:1262, 1968.

• 20) Sonksen, P. H., et al.:Growth hormone and cortisol response to insulin infusion in patients with diabetes mellitus. Lancet, II:155, 1973.

• 21) Alberti, K. G. M. M., et al:Small doses of intramuscular insulin in the treatment of diabetic "coma" . Lancet, 11:515, 1973.

• 22) 後藤由夫ほか:意識障害-糖尿病:, P 265, 臨床症状シリーズ6, 上田英雄 ほか編, 南江堂, 1978.

• 23) 後藤由夫:糖尿病の病態生理と治療, 麻酔, 28:1625, 1979.
  Medical*Online

• 24) Williams, R. H., et al.:The Pancreas. In Textbook of Endocrinology. p. 502, Eds. Williams, K. H., 5th ed., 1974.

• 25) Anderson, H., et al.:Importance of plasma inorganic phosphate in the treatment of diabetic ketoacidosis. Diabetes 22 (Suppl 1):293, 1973.

• 26) Arieff, A. I., et al.:Studies on mechanisms of cerebral edema in diabetic coma. J. Clin. Invest., 52:571, 1973.
  pubmed

• 27) McGarry, J. D., et al.:Regulation of ketogenesis and clinical aspects of the ketotic state. Metabolism, 21:471, 1972.
  pubmed

P.373 掲載の参考文献

• 1) Hasselbalch, K. A.:Die Berechnung der Wasserstoffzahl des Blutes aus der freien und gebundenen Kohlensaure desselben, und die Sauerstoffbindung des Blutes als Funktion der Wasserstoffzahl. Biochem. Z. 78:112, 1916.

• 2) 福井俊夫:酸塩基平衡異常, 血液ガス (山林 一他編集), 医学書院, p. 78, 1978.

• 3) Davenport, H. W.:The ABC of acid. base chemistry. 6th. ed. Univ. Chicago Press, p. 38, 1974.

• 4) 佐竹辰夫, 高木健三:血液ガス分析-CO2含量, 綜合臨牀, 28:1173, 1979.

• 5) BATEs, D. V., MACKLEM, P. T., CHRISTIE, R. V.:Respiratory Function in Disease, W. B. Saunders Co., 1971.

• 6) Peretz, D. I., Mcgreger, M., et al.:Lactic acidosis:A clinically significant aspect of shock. Canad. Med. Ass. J., 90:673, 1964.

• 7) 後藤文夫, 藤田達士:Lactic acidosis. Medicina, 16:1498, 1979.

• 8) Manery, J. F.:Water and electrolyte metabolism. Physiol. Rev., 34:334. 1954.
  pubmed

• 9) Rooth, G.:Acid base and electrolyte balance. Studentlitteratur, Sweden, 1975.

• 10) 和田孝雄:呼吸障害と酸塩基平衡, 医学のあゆみ, 107:404, 1978.

• 11) Gamble, J. L.:Chemical Anatomy, Physiology and Pathology of Extracellular Fluid. Harvard University Press. Cambridge. Mass. 1950.

• 12) Donadio, J. V.:Conservative Management of Chronic Renal Failure. M. Clin. North America, 50:1175-1966.

• 13) Masoro, E. J. and Siegel, P. D.:Acid-Base Regulation. Its physiology and pathophysiology, Saunders, Philadelphia, 1971.

• 14) 藤田一誠:慢性呼吸不全, とくにchronic hypercapnia例におけるpH上昇 (alkalemia) に関する臨床的研究. 日内会誌, 64:1219, 1975.

• 15) Willson, R. S. and Rie, M. A.:Management of mechanical ventilation. Surg. Clin. N. Am., 55:591, 1975.

• 16) 佐竹辰夫:呼吸管理-慢性閉塞性肺疾患を中心として-, 現代医学, 24: 125, 1976.

• 17) National Heart and Lung Institute and American Thoracic Society:Proc. of the conference on the scientific basis of respiratory therapy. Amer. Rev. Respir. Dis., 110 (No. 6. part 2):1, 1974.

• 18) 佐竹辰夫:閉塞性肺疾患 (慢性気管支炎と肺気腫), 新内科学大系第28巻C (呼吸器疾患IIIc), 中山書店, p. 3, 1978.

• 19) Nahas, G. G.:Use of buffers in management of respiratory failure. Ann. New York Acd. Sci., 121:871, 1965.

P.380 掲載の参考文献

• 1) Tschirgi, R. D.:"Chemical environment of central nervous system" , in Handbook of Physiology, Vol 3, Section 1:Neurophysiology, ed. by Field, J., American Physiology Society, Washington, D. C., 1960, pp 1865-1890.

• 2) Posner, J. B. & Plum, F:Spinal-fluid pH and neurologic symptoms in systemic acidosis. New Eng, J. Med., 277,:605-613, 1967.
  pubmed

• 3) Swanson, A. G., Stavney, L. S. & Plum, F.:Effects of blood pH and carbon dioxide on cerebral electrical activity. Neurology, 8:787-792, 1958.
  pubmed

• 4) Mitchell, R. A. & Singer, M. M.:Respiration and cerebrospinal fluid pH in metabolic acidosis and alkalosis. J. Appl. Physiol., 20:905-911, 1965.
  pubmed

• 5) Mitchell, R. A., Carman, C. T., Severinghaus, J. W., Richardson, B. W., Singer, M. M. & Shnider, S.:Stability of cerebrospinal fluid pH in chronic acid-base disturbances in blood. J, Appl. Physiol., 20:443-452, 1965.
  pubmed

• 6) Posner, J. B., Swanson, A. G. & Plum, F.:Acid-base balance in cerebrospinal fluid. Arch. Neurol., 12:479-496, 1965.
  pubmed

• 7) Katzman, R. & Pappius, H. M.:"Brain Electrolytes and Fluid Metabolism, " The Williams & Wilkins Co., Baltimore, 1973.

• 8) Mitchell, R. A., Herbert, D. A. & Carman, C. T.:Acid. base constants and temperature coefficients for cerebrospinal fluid., J. Appl. Physiol, 20127-30, 1965.

• 9) Bradley R. D. & Semple, S. J. G.:A comparison of certain acid-base characteristics of arterial blood, jugular venous blood and cerebrospinal fluid in man, and the effect on them of some acute and chronic acid-base disturbances. J. Physiol. (London), 160:381-391, 1962.

• 10) Fisher, V. J. & Christianson, L C.:Cerebrospinal fluid acid-base balance during a changing ventilatory state in man. J. Appl. Physiol., 18:712-716, 1963.

• 11) Ponten, U. & Siesjo, B. K.:Gradients of CO2, tension in the brain. Acta Physiol. Scand., 67:129-140, 1966.
  pubmed

• 12) Leusen, I. R.:Acid-base equilibrium between blood and cerebrospinal fluid. Amer. J. Physiol., 176:513-516, 1954.
  pubmed

• 13) Pappenheimer, J. R., Fencl, V., Heisey, S. R., & Held, D.:Role of cerebral fluids in control of respiration as studied in unanesthetized goats. Am. J. Physiol., 208:436-450, 1965.
  pubmed

• 14) Shinohara, Y.:Mechanism of chemical control of cerebral vasomotor activity. Neurology, 23:186-195, 1973.

• 15) Severinghaus, J. W., Mitchell R. A., Richardson, B. W., & Singer, M. M.:Respiratory control at high altitudes suggesting active transport regulation of CSF pH. J. Appl. Physiol., 18:1155-1166, 1963.
  pubmed

• 16) Meyer, J. S., Gotoh, F. & Tazaki, Y.:CO2 narcosis. Neurology, 11:524-537, 1961.
  pubmed

• 17) 後藤文男, 篠原幸人:肺性脳症. 臨床科学, 6:972-982, 1970.

• 18) 篠原幸人:CO2ナルコーシス, メディチーナ. 12:12-13, 1975.

• 19) Lee, J. E., Chu, F., Posner, J. B. & Plum, F.:Buffering capacity of cerebrospinal fluid in acute respiratory acidosis in dogs. Amer. J. Physiol., 217:1035-1038, 1969.
  pubmed

• 20) 後藤文男, 篠原幸人:脳循環・代謝と脳波. 臨床脳波, 15:203-214, 1973.

• 21) 篠原幸人, 吉井文均:著明なlactic acidosisを呈したクモ膜下出血の一剖検例. 脳卒中, 2:28-32, 1980.

• 22) Lockman, L. A.:"Neurological aspects of acid-base metabolism." In Handbook of Clinical Neurology. ed. by Vinken, P. J. & Bruyn, G. W., Vol. 28, North-Holland Publ. Co., Amsterdam, 1976, pp. 507-525.

P.395 掲載の参考文献

• 1) Marriot:Water and Salt Depletion, Springfield, London (1950).

• 2) Talbot, N. B. et al:New Engl. J. Med., 248:110 (1953).

• 3) 阿部裕他:内科, 26:607 (1970).

• 4) Maxwell, M. H. & Kleeman, C. R.:Clinical Disorders of Fluid and Electrolyte Metabolism, 3rd ed., McGraw-Hill, New York (1972).

• 5) 加藤暎一, 越川昭三:水電解質の基礎と臨床, 真興交易医書出版部, 東京 (1973).

• 6) Guyton, A. C. & Jones, C. E.:Am. Heart J., 86:431 (1973).
  pubmed

• 7) 越川昭三:輸液, 第3版, 中外医学社, 東京 (1974).

• 8) 飯田喜俊:図解水と電解質, 第5版, 中外医学社, 東京 (1975).

• 9) Goldberger, E.:A Primer of Water Electrolyte and Acid・base Syndromes, 5th ed., Lea & Febiger, Philadelphia (1975).

• 10) 阿部裕ほか:輸液剤の種類と適応, 体液の乱れ (上田, 武内, 豊倉編), 南江堂, 東京, p. 311 (1978).

• 11) 安東明夫ほか:治療学, 3:572, 1979.

• 12) 砂田輝武ほか:輸液療法の実際, 金原出版, 東京 (1975).

P.402 掲載の参考文献

• 1) 宮原 正:中毒による腎障害, 内科46:936, 1980.

• 2) Bennet, W. M.:Clinical syndromes of drug nephrotoxicity. In drugs and renal disease, Monographs in clinical Parmacology, Vol 2., Churchill Livingstone, New York, p 65, 1978.

• 3) Miller, M. and Moses, A. M.:Drug-induced states of impaired water excretion. Kidney Int., 10:96, 1976.
  pubmed

• 4) Miller, M. and Moses, A. M.:Mechanism of Chlorpropamide action in diabetes illsipidus. J. Clin. Endocrinol. metab. 30:488, 1970.
  pubmed

• 5) Singer, I and Torrest, J. N.:Drug-induced states of nephrogenic diabetes insipidus, Kidney Int., 10:82, 1976.

• 6) Weissman, P. N., Shenkman, L, and Gregerman R. I. 1:Chlorpropamide hyponatremia; Drug-induced inappropriate autidiuretic-hormone activity. New Engl. J. Med, 284:65, 1971.

• 7) Lozada, E. S., Gouaux, J., Tranki, N., Appel, G. B, and Hays, R. M.:Studies of the mode of action of the sulfonylureas and phenylacetamides in enhancing the effect of vasopressin. J. Clin. Endocrinol. Metab. 34:704, 1972.

• 8) Katsuki, S., Ito. M.,:Antidiuretic effect of biguanides. Lancet. 2:630, 1966.

• 9) Eisenberg, E.:The mechanism of the biguanide effect of diabetes insipidus. Clin. Res. 18:168, 1970.

• 10) Uhlich, E., Loeschke, K., Eigler, J.:Zur antidiuretischen wirkung von carbamazepin bei diabetes insipidus. Klin. Wochensch 50:1127, 1972.

• 11) Moeses, A. M., Howanitz, J., Van Gemert, M, . Miller, M.:Clofibrate-induced antidiuresis. J. Clin. Invest. 52:535, 1973.

• 12) Radi. J. P.:Water intoxication during carbamazepin treatment. Brit. Med. J. 3:479, 1973.

• 13) Kimura, T., Matsui, K., Sato, T., Yoshinaga, K.:Mechanism of carbamazepin (Tegretol)-induced antidiuresis; Evidence for release of antidiuretic hormone and impaired excretion of a water load. J. Clin. Endocrinol. Metab. 38:356, 1974.
  pubmed

• 14) Cutting, H. O.:Inappropriate secretion of antidiuretic hormonesecondary to vincristin therapy. Am. J. Med., 51:269, 1971.

• 15) Robertson, S., Kaufman, S.:Vincristin neurotoxicity and abnormal secretion of antidiuretic hormone. Arch. intern. Med, . 132:712, 1973.

• 16) Steele, T. H., Serpick, A. A., Block, J. B.:Antidiuretic response to cyclophosphamide in man. J. Pharmacol. Exp. Ther., 185:245, 1973.

• 17) Crandell, W. B., Pappas, S. G., Mac Donald, A.:Nephrotoxicity associated with methoxyflurane anesthesia. Anesthesiology, 27:591, 1966.

• 18) Paddock, R. B., Parker, J. W., Guadagni, N. P.:The effects of methoxy flurane on renal function. Anesthesiology, 25:707, 1964.

• 19) Singer, I. and Rotenberg, D.:Demeclocyclin-induced nephrogenic diabetes insipidus. Ann. Intern. Med., 79:679, 1973.

• 20) Huckabee, W. F.:Abnormal resting blood lactate. Lactic acidosis. Amer. J. Med., 30:840, 1961.

• 21) Fulop, M.,Hoberman, H. D.:Phenformin associated metabolic acidosis.Diabetes, 25:292,1976.
  pubmed

• 22) Steele, T. W., Gyory, A. Z., and Edwards, K. G.:Renal function in analgesic nephropathy. Brit. Med. J.,26:213,1969.

• 23) Gross, J. M.:Fanconi's syndrome (adult type) developing secondary to the ingestion of outdated tetracycline. Ann. Intern. Med., 58:523, 1963.

• 24) Frinpter, G. W., Timpanelle, A. E., Eisenmenger, W. J., Stein, H. S. and Ehrlich, L. I.:Reversible "Fanconi's syndrome caused by degraded tetracycline. JAMA. 184:111, 1963.

• 25) Wegienka, L. C., Weller, J. M. and Mick, A. A.:Renal tubular acidosis by degraded tetracycline. Arch. Intern. Med., 114:232, 1964.

• 26) Benity, K. F., Diermeier, H. F.:Renal toxicity of tetracycline degradation products. Proc. Soc. Exp. Med., 115:930, 1964.

• 27) Otten, J., and Vis, H. L.:Acute reversible renal tubular dysfunction following intoxication with methyl-3-Chromone. J. Ped., 73:422, 1968.

• 28) Weissman, G., Pras, M., and Hirshorn, R. A.:Common mechanism for the fungicidal and nephrotoxic effects of amphotericin B. J. Clin. Invest., 45:1084, 1966.

• 29) Mc Curdy, D. K., Frederic, M., and Elkinton, J. R.:Renal tubular acidosisd ue to amphotericin B. New Engl J. Med., 278:124, 1968.

P.409 掲載の参考文献

• 1) 詫摩武英:老年者の免疫疾患-腎疾患, Geriatric Medicine (老年医学), 18 :939, 1980.

• 2) 詫摩武英, 三村信英:慢性腎不全の治療-腹膜透析の応用, 日獨医報, 17: 553, 1972.

• 3) Raja, R. M., Cantor, R. E., Boreyko, C., Bushehri, H., Kramer, M. S., and Rosenbaum, J. L.:Sodium transport during ultrafiltration peritoneal dialysis. Trans. Amer. Soc. Artif. Int. Organs, 18:429, 1972.

• 4) Ahearn, D. J. and Nolph, K. D.:Controlled sodium removal with peritoneal dialysis. Trans. Amer. Soc. Artif. Int. Organs, 18:423, 1972.